{"add": {"doc": {"field": [{"@name": "docid", "#text": "BR-TU.07701"}, {"@name": "filename", "#text": "12426_me_germana_borges.pdf"}, {"@name": "filetype", "#text": "PDF"}, {"@name": "text", "#text": "Universidade de S\u00e3o Paulo \n\nFaculdade de Odontologia de Ribeir\u00e3o Preto \n\nDepartamento de Cirurgia e Traumatologia Buco-Maxilo-Facial e Periodontia \n\n \n\n \n\n \n\n \n\n \n\n \n\nAvalia\u00e7\u00e3o do uso da matriz d\u00e9rmica acelular como barreira na \n\nregenera\u00e7\u00e3o \u00f3ssea guiada. Estudo cl\u00ednico, radiogr\u00e1fico e \n\nhistomorfom\u00e9trico em c\u00e3es. \n\n \n\n \n\n \n\n \n\nGermana Jayme Borges \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\nRibeir\u00e3o Preto \n\n2008\n\n\n\n \n\nGermana Jayme Borges \n\n \n\n \n\n \n\n \n\n \n\n \n\nAvalia\u00e7\u00e3o do uso da matriz d\u00e9rmica acelular como barreira na \n\nregenera\u00e7\u00e3o \u00f3ssea guiada. Estudo cl\u00ednico, radiogr\u00e1fico e \n\nhistomorfom\u00e9trico em c\u00e3es. \n\n \n\n \n\n \n\nDisserta\u00e7\u00e3o apresentada \u00e0 Faculdade de \n\nOdontologia de Ribeir\u00e3o Preto \u2013 USP como \n\nparte dos requisitos para a obten\u00e7\u00e3o do \n\nt\u00edtulo de Mestre em Periodontia. \n\n \n\n \n\nOrientador: Prof. Dr. S\u00e9rgio Lu\u00eds \n\nScombatti de Souza \n\n \n\n \n\n \n\nRibeir\u00e3o Preto \n\n2008 \n\n\n\n \n\nAutorizo a reprodu\u00e7\u00e3o e divulga\u00e7\u00e3o total ou parcial deste trabalho, por qualquer \n\nmeio convencional ou eletr\u00f4nico, para fins de estudo e pesquisa, desde que citada a \n\nfonte \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \nBORGES, Germana Jayme  \n\n \n\nAvalia\u00e7\u00e3o do uso da matriz d\u00e9rmica acelular como barreira na \n\nregenera\u00e7\u00e3o \u00f3ssea guiada. Estudo cl\u00ednico, radiogr\u00e1fico e histomorfom\u00e9trico \n\nem c\u00e3es. Ribeir\u00e3o Preto, 2008. \n\n           108p. : il. ; 30 cm. \n\n \n\n           Disserta\u00e7\u00e3o de Mestrado, apresentada \u00e0 Faculdade de Odontologia de \n\nRibeir\u00e3o Preto/USP \u2013 \u00c1rea de concentra\u00e7\u00e3o: Periodontia. \n\n           Orientador: Souza, S\u00e9rgio Lu\u00eds Scombatti de \n\n \n\n1. Matriz d\u00e9rmica acelular; 2. Membrana; 3. Regenera\u00e7\u00e3o \u00d3ssea Guiada.  \n\n\n\n \n\nFOLHA DE APROVA\u00c7\u00c3O \n\n \nGermana Jayme Borges \n\n \n\nAvalia\u00e7\u00e3o do uso da matriz d\u00e9rmica acelular como barreira na \n\nregenera\u00e7\u00e3o \u00f3ssea guiada. Estudo cl\u00ednico, radiogr\u00e1fico e \n\nhistomorfom\u00e9trico em c\u00e3es. \n \n\nDisserta\u00e7\u00e3o apresentada \u00e0 Faculdade de Odontologia \n\nde Ribeir\u00e3o Preto da Universidade de S\u00e3o Paulo para \n\nobten\u00e7\u00e3o do t\u00edtulo de Mestre. \n\n\u00c1rea de Concentra\u00e7\u00e3o: Periodontia \n\n \n\n \n\nAprovado em: ____ / ____ / 2009 \n\n \n\nBanca Examinadora \n\n \n\nProf.Dr. ____________________________________________________________ \n\nInstitui\u00e7\u00e3o: _________________________ Assinatura: _______________________ \n\n \n\nProf.Dr. ____________________________________________________________ \n\nInstitui\u00e7\u00e3o: _________________________ Assinatura: _______________________ \n\n \n\nProf.Dr. ____________________________________________________________ \n\nInstitui\u00e7\u00e3o: _________________________ Assinatura: _______________________ \n\n\n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\nDedicat\u00f3ria \n\n \n\n\n\n \n\n \n\n \n\nDedico este trabalho \u00e0s pessoas mais importantes e essenciais em \n\nminha vida... \n\n \n\n \n\nMeus pais, Jos\u00e9 Sizenando e Maria Helena. \n\n \n\n \n\nPor voc\u00eas tenho os mais profundos sentimentos... Amor, respeito, \n\nadmira\u00e7\u00e3o, gratid\u00e3o... \n\n \n\n \n\nObrigada por nosso lar estruturado, pelo amor que sempre me \n\ndedicaram, pelo exemplo de f\u00e9, por estarem ao meu lado em todos os \n\nmomentos. \n\n \n\n \n\n \n\n \n\n \n\n\n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\nAgradecimentos \n\n\n\n \n\n \n\n \n\n\u00c0 Deus, \n\n \n\nO Senhor \u00e9 o meu pastor e nada me faltar\u00e1; \n\nEle me d\u00e1 novas for\u00e7as; \n\ne me guia no caminho certo \n\nAinda que eu caminhe por um vale escuro \n\nn\u00e3o temerei. \n\nPois Deus est\u00e1 comigo, \n\nTu me proteges e me diriges. \n\nSei que a tua bondade e o teu perd\u00e3o \n\nficar\u00e3o comigo enquanto eu viver. \n\nE todos os dias da minha vida \nmorarei na tua casa \n\n \n\nSalmo 23 \n\n \n\n \n\n \n\n \n\n\n\n \n\nAos meus irm\u00e3os, Liana e Gabriel, pelo amor, incentivo e amizade. Voc\u00eas s\u00e3o \n\nmeus melhores amigos e eternos companheiros.  \n\n \n\nAo meu querido av\u00f4, Leyde Jayme, por ser meu exemplo, minha alegria...por \n\nestar ao meu lado em todos os momentos...mesmo agora quando sua presen\u00e7a \n\nf\u00edsica n\u00e3o \u00e9 sentida.  \n\n \n\n\u00c0 minha querida av\u00f3 Terezinha, por ser nossa fortaleza! V\u00f3, amo muito a \n\nsenhora e estarei sempre ao seu lado cuidando de voc\u00ea. \n\n \n\nAos meus av\u00f3s Jos\u00e9 Randolfo e Esther, pelo exemplo de vida, pelos bons \n\nmomentos que juntos compartilhamos. \n\n \n\nAo meu orientador Prof\u00ba.Dr. S\u00e9rgio Luis Scombatti de Souza,, \n\n \n\nProfessor...muito obrigada por tudo!  \n\nPor acreditar em meu potencial e por ter estado sempre ao meu lado, me \n\nincentivando e apoiando. \n\nObrigada pelos conhecimentos transmitidos, pela amizade  e por fazer parte direta \n\ndessa importante conquista em minha vida! \n\n \n\nAos docentes do Curso de P\u00f3s-Gradua\u00e7\u00e3o Prof\u00ba. Dr. Arthur Bel\u00e9m \n\nNovaes Jr., Prof\u00ba. Dr. M\u00e1rcio Fernando de Moraes Grisi, \n\n\n\n \n\nProf\u00aa. Dr\u00aa. Daniela Bazan Palioto, Prof\u00ba. Dr. M\u00e1rio Taba \n\nJr. pela forma\u00e7\u00e3o e exemplo. \n\n \n\nAo coordenador do Curso de P\u00f3s-Gradua\u00e7\u00e3o \u2013 \u00c1rea de Periodontia Prof\u00ba.Dr. \n\nArthur Bel\u00e9m Novaes Jr., pela compet\u00eancia, dedica\u00e7\u00e3o, responsabilidade \n\ne apoio. \n\n \n\nAo professor M\u00e1rcio Grisi, cujo entusiasmo pela profiss\u00e3o sempre me inspirou \n\ne estimulou a lutar por meus ideais como cirurgi\u00e3-dentista. \n\n \n\nAos animais  envolvidos nessa pesquisa, que sempre me transmitiram lealdade e \n\ncom os quais muito aprendi.... \n\n \n\n\u00c0 Patr\u00edcia, amiga e companheira. Pat, n\u00e3o tenho palavras para expressar o \n\nquanto foi importante conviver e aprender com voc\u00ea ao longo desses anos. Obrigada \n\npela \u00f3tima conviv\u00eancia em casa, pela cumplicidade e carinho. Seu apoio e incentivo \n\nforam fundamentais para que eu chegasse at\u00e9 aqui. Voc\u00ea sempre estar\u00e1 em minhas \n\nora\u00e7\u00f5es .Com certeza nossa parceria n\u00e3o termina aqui! \n\n \n\n\u00c0s colegas de mestrado, Fl\u00e1via, Adriana, Priscila, Annelissa e \n\nPriscila Paganini, que se tornaram minhas grandes amigas e companheiras. \n\nJuntas vencemos \u00e0 dist\u00e2ncia da fam\u00edlia, as dificuldades do curso e agora, \n\n\n\n \n\nnovamente juntas, celebramos a alegria da vit\u00f3ria. Cada uma, de uma forma \n\nespecial contribuiu para o meu crescimento pessoal e profissional. Serei \n\neternamente grata por tudo que fizeram por mim ao longo desses anos. Contem \n\ncomigo sempre! Amo voc\u00eas. \n\n \n\nAos colegas de doutorado, Rafael , Guilherme e Raquel. Muito obrigada \n\npelas oportunidades que me proporcionaram, pela confian\u00e7a e aten\u00e7\u00e3o. Voc\u00eas s\u00e3o \n\num exemplo de esfor\u00e7o, supera\u00e7\u00e3o e dedica\u00e7\u00e3o. Sucesso! \n\n \n\nAo veterin\u00e1rio F\u00e1bio que se tornou um importante e querido amigo. Sua \n\ncompet\u00eancia, disponibilidade, e dedica\u00e7\u00e3o s\u00e3o um exemplo e foram indispens\u00e1veis \n\npara o sucesso dessa pesquisa.  \n\n \n\nAos funcion\u00e1rios do biot\u00e9rio, Aldo e Edson, pelo apoio incondicional com os \n\nc\u00e3es, e por tornarem meus momentos no biot\u00e9rio mais alegres e divertidos.  \n\n \n\n\u00c0s queridas funcion\u00e1rias Tati, Dulce, Sueli e Zilda, pelo aux\u00edlio, aten\u00e7\u00e3o e \n\nsobretudo pelo carinho e amizade!  \n\n \n\nAo professor Luis Fernando Naldi Ruiz, cuja compet\u00eancia e habilidade \n\nprofissional despertaram em mim o interesse pela Periodontia. Agrade\u00e7o ainda o  \n\nincentivo para que seguisse a carreira acad\u00eamica.  \n\n \n\n\n\n \n\n\u00c0s minhas fi\u00e9is amigas Marlei e Karina, que mesmo \u00e0 dist\u00e2ncia fizeram parte \n\ndessa etapa de minha vinha.  \n\n \n\n\u00c0 amiga Paulinha, que sempre me apoiou e proporcionou momentos de alegria \n\ne divers\u00e3o. \n\n \n\nAos meus pacientes, aqui representados pela Eliana Xicatto, que se tornou \n\numa querida amiga. \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n\n\n \n\n \n\n\u201cTua caminhada ainda n\u00e3o terminou... \n\nA realidade te acolhe \ndizendo que pela frente \n\no horizonte da vida necessita \nde tuas palavras \n\ne do teu sil\u00eancio. \nSe amanh\u00e3 sentires saudades, \n\nlembra-te da fantasia e \nsonha com tua pr\u00f3xima vit\u00f3ria. \n\nVit\u00f3ria que todas as armas do mundo \njamais conseguir\u00e3o obter, \n\nporque \u00e9 uma vit\u00f3ria que surge da paz \ne n\u00e3o do ressentimento. \n\n\u00c9 certo que ir\u00e1s encontrar situa\u00e7\u00f5es \ntempestuosas novamente, \n\nmas haver\u00e1 de ver sempre \no lado bom da chuva que cai \n\ne n\u00e3o a faceta do raio que destr\u00f3i. \nTu \u00e9s jovem. \n\nAtender a quem te chama \u00e9 belo, \n\nlutar por quem te rejeita \n\u00e9 quase chegar \u00e0 perfei\u00e7\u00e3o. \n\nA juventude precisa de sonhos \ne se nutrir de lembran\u00e7as, \n\nassim como o leito dos rios \nprecisa da \u00e1gua que rola \n\ne o cora\u00e7\u00e3o necessita de afeto. \nN\u00e3o fa\u00e7as do amanh\u00e3 \n\no sin\u00f4nimo de nunca, \nnem o ontem te seja o mesmo \n\nque nunca mais. \nTeus passos ficaram. \n\nOlhes para tr\u00e1s... \nmas v\u00e1 em frente \n\npois h\u00e1 muitos que precisam \nque chegues para poderem seguir-te.\u201d \n\n \nCharles Chaplin \n\n\n\n xiii\n\nLISTA DE ABREVIATURAS E SIGLAS \n\n \n\nGT: grupo teste \n\nGC: grupo controle \n\nROG: regenera\u00e7\u00e3o \u00f3ssea guiada \n\nMDA: matriz d\u00e9rmica acelular \n\nPTFE-e: politetrafluoretileno expandido \n\nRTG: regenera\u00e7\u00e3o tecidual guiada \n\nEMQ: espessura de mucosa queratinizada \n\nEMQ-V: espessura de mucosa queratinizada vestibular \n\nEMQ-O: espessura de mucosa queratinizada oclusal \n\nEM-L: espessura de mucosa queratinizada lingual \n\nAMQ: altura de mucosa queratinizada \n\nAMQ-V: altura de mucosa queratinizada vestibular \n\nAMQ-L: altura de mucosa queratinizada lingual \n\nAO: altura \u00f3ssea m\u00e1xima \n\nANT: \u00e1rea de novos tecidos \n\nANO: \u00e1rea de novo osso \n\nNO: novo osso \n\nDO: densidade \u00f3ssea \n\nIR: imagem radiogr\u00e1fica \n\nARD: \u00e1rea radiogr\u00e1fica do defeito \n\nANO-R: \u00e1rea radiogr\u00e1fica de novo osso \n\nDO-R: densidade \u00f3ssea radiogr\u00e1fica \n\nDO-R Co: densidade \u00f3ssea radiogr\u00e1fica coronal \n\n\n\n xiv\n\nDO-R C: densidade \u00f3ssea radiogr\u00e1fica central \n\nDOR-A: densidade \u00f3ssea radiogr\u00e1fica apical \n\nDOR-Cr: densidade \u00f3ssea radiogr\u00e1fica controle \n\nPO-R: preenchimento \u00f3sseo radiogr\u00e1fico \n\nMm: mil\u00edmetros \n\nMm2: mil\u00edmetros quadrados \n\n\u00b5m: micrometros \n\n\n\n xv\n\nSUM\u00c1RIO \n\n \n\n \n\n \n\n \n\n \n\n \n\nJUSTIFICATIVA .......................................................................................................xvii \n\nRESUMO................................................................................................................. xxv \n\nINTRODU\u00c7\u00c3O .......................................................................................................... 28 \n\nMATERIAL E M\u00c9TODOS .......................................................................................... 33 \n\nRESULTADOS .......................................................................................................... 48 \n\nDISCUSS\u00c3O ............................................................................................................. 57 \n\nCONCLUS\u00c3O............................................................................................................ 64 \n\nREFER\u00caNCIAS BIBLIOGR\u00c1FICAS .......................................................................... 66 \n\nARTIGO EM INGL\u00caS ................................................................................................ 77 \n\n \n\n \n\n\n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\nJustificativa \n\n \n\n\n\n xvii\n\nJUSTIFICATIVA \n\n \n\n V\u00e1rios estudos em animais e cl\u00ednicos em humanos demonstraram a \n\npossibilidade de neoforma\u00e7\u00e3o \u00f3ssea atrav\u00e9s da regenera\u00e7\u00e3o \u00f3ssea guiada (ROG) 1-\n\n6. Essa t\u00e9cnica se baseia na utiliza\u00e7\u00e3o de uma barreira f\u00edsica, com o intuito de \n\nimpedir a migra\u00e7\u00e3o de c\u00e9lulas indesej\u00e1veis, oriundas dos tecidos conjuntivo e \n\nepitelial de origem gengival, e dessa maneira viabilizar a forma\u00e7\u00e3o \u00f3ssea. \n\nClassicamente, s\u00e3o utilizadas como barreira membranas n\u00e3o-absorv\u00edveis de \n\npolitetrafluoretileno expandido (PTFE-e)* 7, 8. No entanto, esse tipo de membrana \n\napresenta algumas desvantagens, como alto risco de exposi\u00e7\u00e3o e contamina\u00e7\u00e3o e \n\nnecessidade de uma segunda interven\u00e7\u00e3o cir\u00fargica para sua remo\u00e7\u00e3o, com \n\npossibilidade de um conseq\u00fcente dist\u00farbio nos tecidos em neoforma\u00e7\u00e3o 9, 10.  \n\nMembranas absorv\u00edveis tamb\u00e9m t\u00eam sido utilizadas11 12-14, apresentando \n\nresultados histol\u00f3gicos e cl\u00ednicos semelhantes ao das membranas de PTFE-e15-17 e \n\ncom a vantagem da n\u00e3o necessidade de uma segunda etapa cir\u00fargica para sua \n\nremo\u00e7\u00e3o. Em conseq\u00fc\u00eancia dos bons resultados baseados, sobretudo, no baixo \n\n\u00edndice de complica\u00e7\u00f5es, as membranas absorv\u00edveis tamb\u00e9m se tornaram um padr\u00e3o \n\npara v\u00e1rias situa\u00e7\u00f5es cl\u00ednicas. Normalmente, essas membranas s\u00e3o constitu\u00eddas de \n\ncol\u00e1geno ou por dois diferentes tipos de poli\u00e9steres, isto \u00e9, por \u00e1cido polil\u00e1ctico ou \n\npoliglic\u00f3lico ou ainda pela combina\u00e7\u00e3o de ambos. A membrana feita pelo copol\u00edmero \n\nde \u00e1cido polil\u00e1ctico e poliglic\u00f3lico \u00e9 absorvida atrav\u00e9s de um processo de hidr\u00f3lise \n\nem \u00e1cido l\u00e1ctico e poliglic\u00f3lico, os quais s\u00e3o eliminados atrav\u00e9s do ciclo de Krebs em \n\ng\u00e1s carb\u00f4nico e \u00e1gua 17, 18. Este processo de absor\u00e7\u00e3o, o qual se inicia por volta da \n\nquarta e sexta semanas e parece se completar aproximadamente oito meses ap\u00f3s a \n\n                                                 \n* Gore-Tex, W.L. Gore &amp; Assoc., Flagstaff, AZ, USA) \n\n\n\n xviii\n\nsua coloca\u00e7\u00e3o provoca uma rea\u00e7\u00e3o inflamat\u00f3ria cr\u00f4nica, moderada e de curto prazo \n\nque parece n\u00e3o interferir na regenera\u00e7\u00e3o dos tecidos 16, 17, 19, 20 \n\nEntretanto, determinadas condi\u00e7\u00f5es cl\u00ednicas, como por exemplo, a presen\u00e7a \n\nde vest\u00edbulo raso e/ou uma pequena quantidade e espessura do tecido gengival, \n\naumentam o risco de exposi\u00e7\u00e3o das membranas na cavidade bucal no per\u00edodo p\u00f3s-\n\noperat\u00f3rio, levando a uma contamina\u00e7\u00e3o destas, o que pode prejudicar os \n\nresultados regenerativos 19, 21. \n\nIn\u00fameros estudos t\u00eam utilizado a matriz d\u00e9rmica acelular, biomaterial de \n\norigem al\u00f3gena, em procedimentos mucogengivais, enquanto outros t\u00eam sugerido a \n\ncapacidade deste biomaterial em atuar como membrana nos procedimentos de RTG \n\ne ROG18, 22-27. Al\u00e9m disso, a literatura tem demonstrado a efic\u00e1cia da MDA em \n\nproporcionar aumento da quantidade e espessura do tecido gengival28-32, e \n\ncontamina\u00e7\u00e3o n\u00e3o significativa, mesmo quando exposta na cavidade bucal no \n\nper\u00edodo p\u00f3s-operat\u00f3rio. 33, 34. \n\nEmbora relatos pr\u00e9vios tenham apontado vantagens na utiliza\u00e7\u00e3o da MDA \n\ncomo barreira, tanto em RTG 27 como em ROG23, n\u00e3o h\u00e1 um estudo controlado, em \n\nmodelo animal, avaliando histologicamente o uso deste biomaterial em compara\u00e7\u00e3o \n\na um padr\u00e3o-ouro da literatura. Deste modo, parece ser interessante e justificada a \n\nrealiza\u00e7\u00e3o do presente trabalho de pesquisa. \n\n\n\n xix\n\nRefer\u00eancias Bibliogr\u00e1ficas: \n\n \n\n1. Dahlin C, Sennerby, L., Lekholm, U., Linde, A. &amp; Nyman, S. Generation of new \n\nbone around titanium implants using a membrane technique:an experimental \n\nstudy in rabbits. International Journal of Oral &amp; Maxillofacial Implants \n\n1989;4:19\u201325. \n\n2. Becker W, Becker, B., Handelsman, M., Ochsenbein,C., Albrektsson, T.   . \n\nGuided tissue regeneration for implants placed into extraction sockets: a study \n\nin dogs. Journal of periodontology 1991;62:703\u2013709. \n\n3. Lang NP, H\u00e4mmerle, C.H.F., Br\u00e4gger, U., Lehmann, B. &amp; Nyman SR. Guided \n\ntissue regeneration in jawbone defects prior to implant placement. Clinical oral \n\nimplants research 1994;5:92\u201397. \n\n4. Nyman S, Lang NP, Buser D, Bragger U. Bone regeneration adjacent to \n\ntitanium dental implants using guided tissue regeneration: a report of two \n\ncases. The International journal of oral &amp; maxillofacial implants 1990;5:9-14. \n\n5. Hammerle CH, Jung RE, Feloutzis A. A systematic review of the survival of \n\nimplants in bone sites augmented with barrier membranes (guided bone \n\nregeneration) in partially edentulous patients. Journal of clinical periodontology \n\n2002;29 Suppl 3:226-231; discussion 232-223. \n\n6. Donos N, Kostopoulos L, Tonetti M, Karring T. Long-term stability of \n\nautogenous bone grafts following combined application with guided bone \n\nregeneration. Clinical oral implants research 2005;16:133-139. \n\n7. Dahlin C, Andersson, L. &amp; Linde, A.  . Bone augmentation at fenestrated \n\nimplants by an osteopromotive membrane technique. A controlled clinical \n\nstudy. Clinical Oral Implants Research 1991;2:159\u2013165. \n\n\n\n xx\n\n8. Nevins MM, J.T. . Enhancement of the damaged edentulous ridge to receive \n\ndental implants: a combination of allograft and the Gore-Tex membrane. \n\nInternational Journal of Periodontics and Restorative Dentistry 1992 12:97\u2013\n\n111. \n\n9. Simion M, Baldoni, M., Rossi, P. &amp; Zaffe, D. A comparative study of the \n\neffectiveness of e-PTFE membranes with and without early exposure during \n\nthe healing period. InternationalJournal of Periodontics and Restorative \n\nDentistry 1994;14:167\u2013180. \n\n10. Machtei EE. The effect of membrane exposure on the outcome of regenerative \n\nproceduresin humans: a meta-analysis. . Journal of periodontology 2001 \n\n72:512\u2013516 \n\n11. Lundgren D, Mathisen, T. &amp; Gottlow, J. , . The development of a bioresorbable \n\nbarrier for guided tissue regeneration. Journal of the Swedish Dental \n\nAssociation 1994;86:741\u2013756. \n\n12. Mayfield L, Nobreus N, Attstrom R, Linde A. Guided bone regeneration in \n\ndental implant treatment using a bioabsorbable membrane. Clinical oral \n\nimplants research 1997;8:10-17. \n\n13. Simion M, Misitano, U., Gionso, L. &amp; Salvato, A.  . Treatment of dehiscences \n\nand fenestrations around dental implants using resorbable and \n\nnonresorbablemembranes associated with bone autografts: a comparative \n\nclinical study. International Journal of Oral &amp; Maxillofacial Implants \n\n1997;12:159\u2013167 \n\n14. Llambes F, Silvestre FJ, Caffesse R. Vertical guided bone regeneration with \n\nbioabsorbable barriers. Journal of periodontology 2007;78:2036-2042. \n\n\n\n xxi\n\n15. Schenk RK BD, Hardwick WR, Dahlin C. . Healing pattern of bone \n\nregeneration in membrane-protected defects: a histologic study in the canine \n\nmandible. The International journal of oral &amp; maxillofacial implants 1994;9:13-\n\n29. \n\n16. Rocchietta I, Fontana F, Simion M. Clinical outcomes of vertical bone \n\naugmentation to enable dental implant placement: a systematic review. \n\nJournal of clinical periodontology 2008;35:203-215. \n\n17. Fiorellini JP NM. Localized ridge augmentation/preservation. A systematic \n\nreview. Annals of periodontology / the American Academy of Periodontology \n\n2003;8:321-327. \n\n18. Fowler EB, Breault LG, Rebitski G. Ridge preservation utilizing an acellular \n\ndermal allograft and demineralized freeze-dried bone allograft: Part II. \n\nImmediate endosseous implant placement. Journal of periodontology \n\n2000;71:1360-1364. \n\n19. Anderegg CR MD, Nicoll BK. . Gingiva thickness in guided tissue regeneration \n\nand associated recession at facial furcation defects. J Periodontol \n\n1995;66:397-402. \n\n20. von Arx T, Broggini N, Jensen SS, Bornstein MM, Schenk RK, Buser D. \n\nMembrane durability and tissue response of different bioresorbable barrier \n\nmembranes: a histologic study in the rabbit calvarium. The International \n\njournal of oral &amp; maxillofacial implants 2005;20:843-853. \n\n21. Machtei EE. The effect of membrane exposure on the outcome of regenerative \n\nprocedures in humans: a meta-analysis. Journal of periodontology \n\n2001;72:512-516. \n\n\n\n xxii\n\n22. Fowler EB, Breault LG, Rebitski G. Ridge preservation utilizing an acellular \n\ndermal allograft and demineralized freeze-dried bone allograft: Part I. A report \n\nof 2 cases. Journal of periodontology 2000;71:1353-1359. \n\n23. Novaes AB, Jr., Souza SL. Acellular dermal matrix graft as a membrane for \n\nguided bone regeneration: a case report. Implant Dent 2001;10:192-196. \n\n24. Novaes AB, Jr., Papalexiou V, Luczyszyn SM, Muglia VA, Souza SL, Taba \n\nJunior M. Immediate implant in extraction socket with acellular dermal matrix \n\ngraft and bioactive glass: a case report. Implant Dent 2002;11:343-348. \n\n25. Griffin TJ, Cheung WS, Hirayama H. Hard and soft tissue augmentation in \n\nimplant therapy using acellular dermal matrix. The International journal of \n\nperiodontics &amp; restorative dentistry 2004;24:352-361. \n\n26. Luczyszyn SM, Papalexiou V, Novaes AB, Jr., Grisi MF, Souza SL, Taba M, \n\nJr. Acellular dermal matrix and hydroxyapatite in prevention of ridge \n\ndeformities after tooth extraction. Implant Dent 2005;14:176-184. \n\n27. de Andrade PF, de Souza SL, de Oliveira Macedo G, et al. Acellular dermal \n\nmatrix as a membrane for guided tissue regeneration in the treatment of Class \n\nII furcation lesions: a histometric and clinical study in dogs. Journal of \n\nperiodontology 2007;78:1288-1299. \n\n28. Seibert J, Nyman S. Localized ridge augmentation in dogs: a pilot study using \n\nmembranes and hydroxyapatite. Journal of periodontology 1990;61:157-165. \n\n29. Lindhe J PR, Berglundh T, Araujo M. . The effect of flap management and \n\nbioresorbable occlusive devices in GTR treatment of degree III furcation \n\ndefects. An experimental study in dogs. Journal of clinical periodontology \n\n1995;22:276-283. \n\n\n\n xxiii\n\n30. Novaes AB, Jr., Grisi DC, Molina GO, Souza SL, Taba M, Jr., Grisi MF. \n\nComparative 6-month clinical study of a subepithelial connective tissue graft \n\nand acellular dermal matrix graft for the treatment of gingival recession. \n\nJournal of periodontology 2001;72:1477-1484. \n\n31. Andrade PF, Felipe ME, Novaes AB, Jr., et al. Comparison between two \n\nsurgical techniques for root coverage with an acellular dermal matrix graft. \n\nJournal of clinical periodontology 2008;35:263-269. \n\n32. Paolantonio M, Dolci M, Esposito P, et al. Subpedicle acellular dermal matrix \n\ngraft and autogenous connective tissue graft in the treatment of gingival \n\nrecessions: a comparative 1-year clinical study. Journal of periodontology \n\n2002;73:1299-1307. \n\n33. Aichelmann-Reidy ME, Yukna, R. A.,Evans, G. H.Nasr, H. F.,Mayer, E. T. \n\nClinical evaluation of acellular allograft dermis for the treatment of human \n\ngingival recession. Journal of periodontology 2001;72:998-1005. \n\n34. Novaes AB Jr GD, Molina GO, Souza SLS, Taba M Jr, Grisi MFM. \n\nComparative 6- month clinical study of a subepithelial connective tissue graft \n\nand acellular dermal matrix for the treatment of gingival recession. Journal of \n\nperiodontology 2001;72:1477-1484. \n\n\n\n xxiv\n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\nResumo \n\n \n\n\n\n xxv\n\nRESUMO \n\n \n\nObjetivo: O presente estudo avaliou, clinica e histomorfometricamente, a matriz \n\nd\u00e9rmica acelular (MDA) como barreira f\u00edsica na regenera\u00e7\u00e3o \u00f3ssea guiada. \n\nMateriais e M\u00e9todos: Inicialmente foram extra\u00eddos, em seis c\u00e3es, os quatro pr\u00e9-\n\nmolares mandibulares bilateralmente. Ap\u00f3s um per\u00edodo de seis semanas, foram \n\nanalisadas a quantidade e qualidade de mucosa ceratinizada (Exame Cl\u00ednico 1). \n\nDuas semanas depois, os animais foram submetidos a um segundo procedimento \n\ncir\u00fargico (Confec\u00e7\u00e3o do defeito e Regenera\u00e7\u00e3o \u00d3ssea Guiada \u2013 ROG), no qual foi \n\ncriado um defeito \u00f3sseo padronizado em cada lado da mand\u00edbula. Sobre o defeito de \n\num hemiarco, escolhido aleatoriamente, foi posicionada e fixada a membrana \n\nabsorv\u00edvel de copol\u00edmeros de \u00e1cido polil\u00e1tico e poliglic\u00f3lico e carbonato trimetileno \n\n(Grupo Controle - GC) e no defeito do hemiarco oposto, a matriz d\u00e9rmica acelular - \n\nMDA (Grupo Teste - GT). Imediatamente ap\u00f3s a sutura, foram feitas tomadas \n\nradiogr\u00e1ficas padronizadas atrav\u00e9s de raio-X digital, as quais foram novamente \n\nrealizadas 8 e 16 semanas ap\u00f3s a cirurgia de coloca\u00e7\u00e3o das membranas. Ap\u00f3s \n\nquatorze semanas de cicatriza\u00e7\u00e3o, a quantidade e qualidade da mucosa \n\nceratinizada foram novamente avaliadas (Exame Cl\u00ednico 2). Dezesseis semanas \n\ndepois da ROG os animais foram sacrificados e foi ent\u00e3o realizado o preparo \n\nhistol\u00f3gico das pe\u00e7as. A an\u00e1lise histomorfom\u00e9trica, em microscopia \u00f3ptica, avaliou a \n\nquantidade e qualidade de osso neoformado. A neoforma\u00e7\u00e3o \u00f3ssea tamb\u00e9m foi \n\nquantificada atrav\u00e9s das imagens radiogr\u00e1ficas.  \n\nResultados: Em rela\u00e7\u00e3o aos par\u00e2metros cl\u00ednicos, o GT e o GC apresentaram \n\naumento na EMQ e redu\u00e7\u00e3o na AMQ. Na an\u00e1lise radiogr\u00e1fica, ap\u00f3s o per\u00edodo de 16 \n\nsemanas, as radiografias de subtra\u00e7\u00e3o apresentaram ganho m\u00e9dio de \u00e1rea \n\n\n\n xxvi\n\nradiopaca em rela\u00e7\u00e3o ao defeito inicial de 83,38 % para o GT e de 83,68% para o \n\nGC. Houve um aumento progressivo da densidade radiogr\u00e1fica para ambos os \n\ngrupos, sem diferen\u00e7as estatisticamente significantes. Histologicamente, ap\u00f3s 16 \n\nsemanas o tecido \u00f3sseo apresentou caracter\u00edsticas de um osso predominantemente \n\nmaduro. Histomorfometricamente, a ANO correspondeu a 58,99% da ANT no GT e a \n\n61 % da ANT no GC. A altura \u00f3ssea m\u00e1xima no GT foi de 7,21 \u00b1 0,80 mm e no GC \n\nde 7,70 \u00b1 1,21 mm. A porcentagem de osso cortical na ANO foi de 42,47 % no GT e \n\n38,08 % no GC. N\u00e3o foram observadas diferen\u00e7as estatisticamente significantes \n\nentre os grupos para nenhum destes par\u00e2metros. \n\nConclus\u00e3o: A MDA atuou como barreira mec\u00e2nica na ROG com resultados cl\u00ednicos, \n\nradiogr\u00e1ficos e histomorfom\u00e9tricos similares aos obtidos com a membrana \n\nabsorv\u00edvel. \n\nPalavras-chave: regenera\u00e7\u00e3o \u00f3ssea guiada; matriz d\u00e9rmica acelular, membrana \n\nabsorv\u00edvel \n\n \n\n\n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\nIntrodu\u00e7\u00e3o \n\n \n\n\n\n 28\n\nINTRODU\u00c7\u00c3O \n\n \n\n Na pr\u00e1tica da odontologia, os profissionais encontram dificuldades na \n\nexecu\u00e7\u00e3o do tratamento de seus pacientes em raz\u00e3o de qualidade e quantidade \n\ninsuficientes de tecido \u00f3sseo. Isto \u00e9 uma constante, sobretudo, na \u00e1rea da \n\nimplantodontia. Cada vez mais pacientes procuram os implantes osseointegrados \n\ncomo forma de reabilitar aus\u00eancias dent\u00e1rias. Contudo, um n\u00famero consider\u00e1vel \n\ndestes pacientes necessita de reconstru\u00e7\u00f5es \u00f3sseas para viabilizar o sucesso \n\nest\u00e9tico-funcional dos implantes. Nestes casos, pode-se lan\u00e7ar m\u00e3o das t\u00e9cnicas de \n\nregenera\u00e7\u00e3o \u00f3ssea guiada (ROG)1-5. A ROG tamb\u00e9m est\u00e1 indicada para \n\nregenera\u00e7\u00e3o \u00f3ssea em alv\u00e9olos frescos, para formar osso ao redor de implantes \n\nimediatos e para corre\u00e7\u00e3o de perdas \u00f3sseas que ocorreram durante ou depois da \n\nosseointegra\u00e7\u00e3o dos implantes 1, 6-11.  \n\n A ROG obedece ao mesmo princ\u00edpio biol\u00f3gico da t\u00e9cnica de regenera\u00e7\u00e3o \n\ntecidual guiada (RTG.), que consiste na utiliza\u00e7\u00e3o de barreiras f\u00edsicas para evitar que \n\nos tecidos periodontais incapazes de promover regenera\u00e7\u00e3o entrem em contato com \n\na superf\u00edcie radicular durante o processo de cura 12. O objetivo principal da \n\nregenera\u00e7\u00e3o \u00f3ssea guiada \u00e9 direcionar a neoforma\u00e7\u00e3o \u00f3ssea, evitando que c\u00e9lulas \n\ndo tecido conjuntivo denso proliferem rapidamente, ocupando o espa\u00e7o destinado ao \n\npreenchimento \u00f3sseo 13 14, 15. \n\n Os materiais utilizados como barreira (membrana) devem ser biocompat\u00edveis, \n\na fim de n\u00e3o induzir respostas imunog\u00eanicas. Devem tamb\u00e9m permitir a passagem \n\nde nutrientes e gases e ter uma adequada integra\u00e7\u00e3o tecidual. As caracter\u00edsticas \n\nestruturais destes materiais devem fazer com que impe\u00e7am a prolifera\u00e7\u00e3o apical de \n\nc\u00e9lulas indesej\u00e1veis (c\u00e9lulas epiteliais e do tecido conjuntivo gengival) para a \u00e1rea a \n\n\n\n 29\n\nser regenerada, al\u00e9m de permitir a cria\u00e7\u00e3o e manuten\u00e7\u00e3o de um espa\u00e7o destinado \n\nao co\u00e1gulo, que posteriormente ser\u00e1 ocupado por c\u00e9lulas provenientes do ligamento \n\nperiodontal e do osso alveolar. \u00c9 importante tamb\u00e9m que as barreiras sejam f\u00e1ceis \n\nde manipular e adaptar sobre o defeito a ser regenerado 16. \n\n Membranas absorv\u00edveis e n\u00e3o absorv\u00edveis podem ser utilizadas nos \n\nprocedimentos de ROG 17-19. No entanto, o emprego da membrana n\u00e3o absorv\u00edvel \n\nrequer a realiza\u00e7\u00e3o de um segundo procedimento cir\u00fargico para remov\u00ea-la, o que \n\ngera desconforto ao paciente e risco de perturbar os tecidos neoformados sob a \n\nbarreira 20, 21. As membranas absorv\u00edveis apresentam a vantagem de eliminar a fase \n\ncir\u00fargica de remo\u00e7\u00e3o; entretanto, uma vez expostas e infectadas, s\u00e3o dif\u00edceis de \n\nserem removidas 22. Segundo alguns autores, o uso de membranas absorv\u00edveis \n\ndeve estar associado \u00e0 utiliza\u00e7\u00e3o de substitutos \u00f3sseos ou materiais de \n\npreenchimento para garantir a manuten\u00e7\u00e3o do espa\u00e7o destinado \u00e0 regenera\u00e7\u00e3o 23, \n\n24. Membranas absorv\u00edveis podem ser constitu\u00eddas de col\u00e1geno ou por diferentes \n\ntipos de poli\u00e9steres como o \u00e1cido polil\u00e1tico ou poliglic\u00f3lico, ou ainda pela \n\ncombina\u00e7\u00e3o de ambos. Estudos cl\u00ednicos e experimentais em animais t\u00eam \n\ndemonstrado bons resultados regenerativos e poucas complica\u00e7\u00f5es p\u00f3s-operat\u00f3rias \n\ncom a utiliza\u00e7\u00e3o de barreira absorv\u00edvel composta por um copol\u00edmero de \u00e1cidos \n\npolil\u00e1tico-poliglic\u00f3lico em defeitos infra-\u00f3sseos 25, 26, les\u00f5es de bifurca\u00e7\u00e3o grau II27, 28 \n\ne tratamento de recess\u00f5es gengivais29, 30. A literatura revela n\u00e3o haver diferen\u00e7as \n\ncl\u00ednicas e histol\u00f3gicas significantes entre membranas n\u00e3o absorv\u00edveis de \n\npolitetrafluoretileno expandido (PTFEe) e absorv\u00edveis\u2020, mesmo a longo prazo16, 31, 32.  \n\n Problemas associados ao per\u00edodo de cura, como exposi\u00e7\u00e3o prematura da \n\nmembrana na cavidade oral e poss\u00edvel contamina\u00e7\u00e3o desta, poder\u00e3o ocorrer com o \n\n                                                 \n\u2020 Gore Resolut, W. L. Gore and Associates, Inc., Flagstaff, Arizona, E.U.A \n\n\n\n 30\n\nemprego das membranas absorv\u00edveis e n\u00e3o absorv\u00edveis. A infec\u00e7\u00e3o da barreira \n\npoder\u00e1 gerar complica\u00e7\u00f5es p\u00f3s-cir\u00fargicas graves como abscessos e dor, sendo \n\nnecess\u00e1ria a sua remo\u00e7\u00e3o 22, 33. Alguns autores associaram a contamina\u00e7\u00e3o da \n\nmembrana a menores ganhos \u00f3sseos 34, 35. Entretanto, alguns estudos relataram \n\nque o uso adequado de antibi\u00f3ticos e de agentes qu\u00edmicos locais para controle de \n\nplaca at\u00e9 a remo\u00e7\u00e3o da barreira poder\u00e1 ser eficiente no controle da infec\u00e7\u00e3o, de \n\nmodo que os resultados n\u00e3o ser\u00e3o afetados 36-38. \n\n A matriz d\u00e9rmica acelular (MDA) \u00e9 um material derivado de pele humana, \n\nobtido em bancos de tecidos, do qual s\u00e3o removidos os componentes celulares, \n\nrespons\u00e1veis pela resposta imunol\u00f3gica e incompatibilidade de ant\u00edgenos, \n\npermanecendo a matriz extracelular constitu\u00edda por fibras col\u00e1genas e el\u00e1sticas, \n\nglicosaminoglicanas e glicoprote\u00ednas como laminina e fibronectina. Foi introduzida na \n\nPeriodontia na d\u00e9cada de 1990, como um potencial substituto dos enxertos \n\naut\u00f3genos nas cirurgias mucogengivais. A MDA tem sido indicada para casos de \n\nrecobrimento rad\u00edcula r29, 39, 40, aumento de mucosa queratinizada17, 41, corre\u00e7\u00e3o de \n\ndeformidades de rebordos ed\u00eantulos42 e remo\u00e7\u00e3o de manchas mel\u00e2nicas43, 44. \n\nRecentemente, Andrade et al. (2007)45, demonstraram sua capacidade em atuar \n\ncomo barreira f\u00edsica na RTG, propiciando tamb\u00e9m o aumento da espessura da \n\nmucosa queratinizada. Al\u00e9m disso, este biomaterial foi utilizado em humanos como \n\nbarreira em regenera\u00e7\u00e3o \u00f3ssea guiada, demonstrando vantagens em rela\u00e7\u00e3o \u00e0s \n\nmembranas convencionais 17. A MDA pode ficar exposta \u00e0 cavidade oral, uma vez \n\nque a contamina\u00e7\u00e3o desta parece n\u00e3o ocorrer de forma significativa, e tamb\u00e9m tem \n\na capacidade de proporcionar aumento da faixa de mucosa queratinizada e da \n\nespessura gengival 17, 41. \n\n\n\n 31\n\n Entretanto, embora clinicamente a MDA pare\u00e7a funcionar adequadamente \n\ncomo barreira para a ROG, com algumas vantagens em rela\u00e7\u00e3o \u00e0s membranas, n\u00e3o \n\nexistem estudos controlados em animais que permitam uma compara\u00e7\u00e3o histol\u00f3gica \n\ne um melhor entendimento dos processos biol\u00f3gicos envolvidos.  \n\n Desse modo, este estudo teve como objetivo avaliar a MDA como barreira na \n\nRegenera\u00e7\u00e3o \u00d3ssea Guiada, comparando-a com uma membrana absorv\u00edvel de \n\ncopol\u00edmeros de \u00e1cido polil\u00e1tico e poliglic\u00f3lico e carbonato de trimetileno, analisando \n\ncl\u00ednica, radiogr\u00e1fica e histomorfometricamente a qualidade e quantidade de \n\nregenera\u00e7\u00e3o \u00f3ssea obtida. \n\n\n\n 32\n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\nMaterial e M\u00e9todos \n\n \n\n\n\n 33\n\nMATERIAL E M\u00c9TODOS \n\n \n\n Este estudo foi aprovado pela Comiss\u00e3o de \u00e9tica no uso de animais (CEUA) \n\ndo Campus de Ribeir\u00e3o Preto \u2013 USP (protocolo n\u00b0 06.1.420.53.8). Todos os \n\nprocedimentos experimentais foram realizados subseq\u00fcentemente a esta aprova\u00e7\u00e3o. \n\n \n\nSeq\u00fc\u00eancia Cir\u00fargica do Experimento \n\n As etapas de desenvolvimento do trabalho obedeceram \u00e0 seguinte seq\u00fc\u00eancia: \n\nPreparo inicial, Cirurgia 1 (extra\u00e7\u00e3o dos pr\u00e9-molares mandibulares P1, P2, P3 e P4, \n\ncriando um espa\u00e7o ed\u00eantulo de aproximadamente 50 mm); ap\u00f3s 6 semanas avalia\u00e7\u00e3o \n\nda mucosa queratinizada (Exame cl\u00ednico 1); 2 semanas ap\u00f3s, realiza\u00e7\u00e3o da Cirurgia 2 \n\n(cria\u00e7\u00e3o de um defeito \u00f3sseo retangular bilateralmente e coloca\u00e7\u00e3o da membrana \n\nabsorv\u00edvel\u2021 e da matriz d\u00e9rmica acelular\u00a7); avalia\u00e7\u00e3o radiogr\u00e1fica controle, 8 semanas \n\nap\u00f3s a Cirurgia 2; segunda avalia\u00e7\u00e3o da mucosa queratinizada (Exame cl\u00ednico 2), \n\navalia\u00e7\u00e3o radiogr\u00e1fica final e sacrif\u00edcio dos c\u00e3es 16 semanas ap\u00f3s a Cirurgia 2. \n\n \n\n \n \n\nSele\u00e7\u00e3o dos Animais \n\n Foram selecionados inicialmente 7 c\u00e3es adultos jovens, de ra\u00e7a indefinida, \n\ncom peso variando entre 25 a 35 Kg. Os animais apresentavam dentes \n                                                 \n\u2021 Osseoquest, Gore and Associates, Inc., Flagstaff, Arizona, E.U.A. \n\u00a7  Alloderm, Life Cell Corporation, New Jersey, EUA. \n\nCirurgia 1 \nExame \ncl\u00ednico 1 \n\nCirurgia 2 \nExame \ncl\u00ednico 2 \nSacrif\u00edcio \n\n15 dias 6 semanas 2 semanas 16 semanas  \n\n\n\n 34\n\nmandibulares e maxilares h\u00edgidos, n\u00e3o possu\u00edam les\u00f5es bucais de origem viral e/ou \n\nf\u00fangica, aus\u00eancia de doen\u00e7a periodontal e gozavam de boa sa\u00fade geral. \n\n \n\nPreparo Inicial \n\n Inicialmente, os c\u00e3es receberam tratamento anti-parasit\u00e1rio, complexos \n\npolivitam\u00ednicos, vacinas e foi realizada profilaxia com ultra-som**. As profilaxias e os \n\nprocedimentos cir\u00fargicos de todo o experimento eram realizados ap\u00f3s seda\u00e7\u00e3o dos \n\nanimais. \n\n \n\nCirurgia 1 \u2013 Extra\u00e7\u00e3o dos quatro pr\u00e9-molares mandibulares bilateralmente \n\n Os c\u00e3es foram mantidos em jejum desde a noite anterior ao ato cir\u00fargico. \n\nReceberam inje\u00e7\u00e3o intramuscular do pr\u00e9-anest\u00e9sico Zolazepan a 0,10 ml/kg e \n\nAcepromazina a 0,10ml/kg. A manuten\u00e7\u00e3o anest\u00e9sica foi realizada com anest\u00e9sico \n\nvol\u00e1til dilu\u00eddo em oxig\u00eanio- Isoflurano?- at\u00e9 o fim do ato cir\u00fargico. \n\n Ap\u00f3s anestesia local, retalhos de espessura total foram realizados \n\nbilateralmente na regi\u00e3o dos 4 pr\u00e9-molares mandibulares. Os dentes foram \n\nseccionados no sentido vest\u00edbulo-lingual na regi\u00e3o de bifurca\u00e7\u00e3o para extra\u00e7\u00e3o \n\nindividual das ra\u00edzes, sem preju\u00edzo a nenhuma das paredes \u00f3sseas. Ap\u00f3s as \n\nextra\u00e7\u00f5es, os s\u00edtios foram debridados com remo\u00e7\u00e3o de todo tecido de granula\u00e7\u00e3o e \n\nativa\u00e7\u00e3o dos espa\u00e7os medulares (reservat\u00f3rios de c\u00e9lulas \u00f3sseas endoteliais), \n\natrav\u00e9s da raspagem da cortical \u00f3ssea com cinz\u00e9is. Em seguida, os retalhos foram \n\nreposicionados e suturados com fio absorv\u00edvel 4-0. (Figuras 1, 2,3). \n\n Os animais foram mantidos sob dieta pastosa por 14 dias para evitar ruptura \n\nda sutura. Semanalmente foi realizado o controle da cicatriza\u00e7\u00e3o atrav\u00e9s de \n\naplica\u00e7\u00f5es de digluconato de clorexidina a 0,12%.  \n                                                 \n** Cavitron 3000, Dentsply Mfg. Co., York, PA, E.U.A. \n? Isoflurano, Instituto Bioch\u00edmico, Atibaia-SP. \n\n\n\n 35\n\nAn\u00e1lise cl\u00ednica da quantidade e qualidade da mucosa ceratinizada \n\n Seis semanas ap\u00f3s a Cirurgia 1 foram feitas as medidas iniciais (Exame \n\ncl\u00ednico 1) da altura e espessura de mucosa queratinizada (AMQ e EMQ, \n\nrespectivamente). Para tal, foram confeccionadas placas de acetato sob medida \n\npara cada hemiarco mandibular dos c\u00e3es, nas quais foram realizadas marca\u00e7\u00f5es, \n\nvisando estabelecer de forma padronizada os locais para as medi\u00e7\u00f5es da AMQ e \n\nEMQ (Figura 1A). As marca\u00e7\u00f5es eram feitas na regi\u00e3o do defeito a ser \n\nconfeccionado, sendo uma na vestibular, uma na oclusal e uma na lingual. Um \u00fanico \n\npesquisador realizou todas as medidas cl\u00ednicas do estudo. \n\n A AMQ foi avaliada por vestibular (AMQ-V) e lingual (AMQ-L), sendo, \n\nrespectivamente, a dist\u00e2ncia entre a marca\u00e7\u00e3o oclusal e a linha mucogengival por \n\nvestibular ou lingual. Foi utilizado um compasso de ponta seca e posteriormente \n\nessas medidas foram transferidas para um paqu\u00edmetro (Figuras 1B, 1C e 1D).  \n\n A EMQ foi verificada em tr\u00eas locais, por vestibular (EMQ-V), oclusal (EMQ-O) \n\ne lingual (EMQ-L) (Figuras 1E, 1F e 1G), nos pontos correspondentes \u00e0s marca\u00e7\u00f5es \n\nda placa. Estas medidas foram realizadas com o aux\u00edlio de uma sonda periodontal \n\nmilimetrada associada a um \u201cstop\u201d de borracha. A sonda era posicionada \n\nperpendicularmente \u00e0 superf\u00edcie da mucosa queratinizada, penetrando atrav\u00e9s do \n\ntecido mole at\u00e9 que uma superf\u00edcie dura fosse sentida; o \u201cstop\u201d de borracha era \n\nent\u00e3o colocado em contato direto com a superf\u00edcie externa da mucosa \n\nposteriormente, a sonda era removida, de forma cuidadosa, para que a profundidade \n\nda penetra\u00e7\u00e3o registrada pudesse ser medida por um paqu\u00edmetro (Figura 1H). As \n\nmedidas da EMQ-V, EMQ-O e EMQ-L foram verificadas 3 vezes, sendo calculada \n\numa m\u00e9dia dos valores obtidos.  \n\n\n\n 36\n\n \n\n \n\nFIGURA 1 - A: placas de acetato confeccionadas sob medida para cada hemiarco mandibular dos \nc\u00e3es; B: compasso de ponta seca e paqu\u00edmetro; C medida de AMQ = dist\u00e2ncia entre a marca\u00e7\u00e3o \noclusal e a linha mucogengival por vestibular ou lingual; D: registro da altura de mucosa ceratinizada; \nE,F e G : registro de medida de EMQ por oclusal, vestibular e lingual com o aux\u00edlio de uma sonda \nperiodontal milimetrada e stop de borracha; G: registro da espessura de mucosa queratinizada \n\n \n\n\n\n 37\n\nCirurgia 2 \u2013 Confec\u00e7\u00e3o dos Defeitos e coloca\u00e7\u00e3o da Membrana e da Matriz \n\nD\u00e9rmica Acelular \n\n Decorrido o per\u00edodo de cicatriza\u00e7\u00e3o de 8 semanas, os animais foram \n\nsubmetidos a este segundo procedimento cir\u00fargico. Previamente foi realizada \n\nprofilaxia com ultra-som e aplica\u00e7\u00e3o do digluconato de clorexidina a 0,12% com \n\ngaze. Ap\u00f3s a repeti\u00e7\u00e3o da seq\u00fc\u00eancia de seda\u00e7\u00e3o e anestesia anteriormente citadas, \n\nfoi realizada uma incis\u00e3o no rebordo alveolar com extens\u00e3o de canino a molar \n\n(Figura 2A e 2B). Com o aux\u00edlio de um sindesm\u00f3tomo, um retalho de espessura total \n\nfoi cuidadosamente elevado por vestibular e lingual, expondo todo o rebordo \n\nalveolar. Pr\u00f3ximo \u00e0 base da mand\u00edbula, foi feita a disseca\u00e7\u00e3o de um retalho parcial, \n\npara facilitar a mobiliza\u00e7\u00e3o deste retalho misto (parcial na base + total) quando da \n\nsutura. Em seguida, um defeito \u00f3sseo retangular envolvendo a crista do rebordo foi \n\nconfeccionado bilateralmente com o aux\u00edlio de brocas diamantadas em baixa rota\u00e7\u00e3o \n\ne instrumentos manuais, sob irriga\u00e7\u00e3o constante e abundante com soro fisiol\u00f3gico \n\n(Figura 2C). A dimens\u00e3o de cada defeito foi de 8 mm no sentido \u00e1pico-coronal, 12 \n\nmm no sentido m\u00e9sio-distal e 10 mm no sentido buco-lingual, medidas que \n\nconfiguram um defeito cr\u00edtico46 (Figuras 2D, 2E e 2F). Nas extremidades mesial e \n\ndistal de cada defeito, a uma dist\u00e2ncia de 3 mm da base, foi fixado um parafuso n\u00e3o-\n\nabsorv\u00edvel de tit\u00e2nio como uma marca\u00e7\u00e3o.  \n\n Em um hemiarco, selecionado aleatoriamente, foi adaptada a membrana \n\nabsorv\u00edvel (Osseoquest), sendo este definido como Grupo Controle (GC). A \n\nmembrana foi devidamente recortada de acordo com o formato do defeito e \n\nposicionada de maneira a recobri-lo todo, ultrapassando suas margens de 2 a 3 mm. \n\nA membrana foi mantida em posi\u00e7\u00e3o atrav\u00e9s dos parafusos de tit\u00e2nio fixados pelo \n\nlado vestibular e por dois parafusos fixados pelo lado lingual (Figura 2G). Na \n\n\n\n 38\n\nseq\u00fc\u00eancia, o retalho foi reposicionado e suturado com fio absorv\u00edvel, de modo a \n\nrecobrir totalmente a membrana. A matriz d\u00e9rmica acelular foi adaptada no defeito \n\n\u00f3sseo do hemiarco oposto (Figura 2H) seguindo toda a seq\u00fc\u00eancia anteriormente \n\ndescrita para a membrana, constituindo o Grupo Teste (GT)  \n\n Ap\u00f3s a coloca\u00e7\u00e3o da matriz d\u00e9rmica acelular e sutura do retalho, foram \n\nrealizadas tomadas radiogr\u00e1ficas dos defeitos \u00f3sseos, com o aux\u00edlio de posicionador \n\nindividualizado, previamente confeccionado, e de um sensor digital de imagens. \n\n \n\n Tratamento p\u00f3s-operat\u00f3rio: \n\n Foram administrados por tr\u00eas dias o analg\u00e9sico Cloridrato de tramadol \n\n(50mg/ml)\u2020\u2020 na propor\u00e7\u00e3o de 3mg/kg, a cada 12 horas e o antiinflamat\u00f3rio Ketofen \n\n20? na propor\u00e7\u00e3o de 1 comprimido /20 Kg. Al\u00e9m disso, os animais receberam por 10 \n\ndias o antibi\u00f3tico Espiramicina? na propor\u00e7\u00e3o de 1 comprimido /10 Kg. O controle da \n\ncicatriza\u00e7\u00e3o foi peri\u00f3dico, com controle di\u00e1rio de placa bacteriana atrav\u00e9s de \n\naplica\u00e7\u00f5es de digluconato de clorexidina a 0,12%. Ap\u00f3s 15 dias do ato cir\u00fargico as \n\nsuturas foram removidas e neste per\u00edodo os c\u00e3es foram alimentados com ra\u00e7\u00e3o \n\npastosa.  \n\n                                                 \n\u2020\u2020Tramal\u00ae, Laborat\u00f3rios Pfizer Ltda, S\u00e3o Paulo,sp. \n? Ketofen, Merial Sa\u00fade Animal Ltda, Paul\u00ednia, SP. \n? Stomorgyl 10, Merial Sa\u00fade Animal Ltda, Paul\u00ednia, SP. \n\n\n\n 39\n\n \n\n \n\nFigura 2: A Incis\u00e3o de canino a molar; B \u2013 Dimens\u00f5es do defeito \u00f3sseo no sentido vest\u00edbulo-lingual \n10 mm; C - Dimens\u00f5es do defeito \u00f3sseo no sentido m\u00e9sio-distal = 12 mm; D - Dimens\u00f5es do defeito \n\u00f3sseo no sentido \u00e1pico-coronal; E - Membrana absorv\u00edvel posicionada, adaptada e fixada; F: suturas; \nG - Matriz D\u00e9rmica Acelular posicionada, adaptada e fixada; H: suturas  \n\n \n\n\n\n 40\n\nAvalia\u00e7\u00e3o Radiogr\u00e1fica Controle \n\n Oito semanas ap\u00f3s a Cirurgia 2, os animais foram sedados conforme descrito \n\nanteriormente, e foram realizadas novas tomadas radiogr\u00e1ficas dos defeitos \u00f3sseos, \n\ndo mesmo modo previamente citado . \n\n \n\nSacrif\u00edcio dos c\u00e3es \n\n Os animais foram sacrificados 16 semanas ap\u00f3s a Cirurgia 2, com uma alta \n\ndose de thiopental s\u00f3dico e posteriormente cloreto de pot\u00e1ssio. Previamente ao \n\nsacrif\u00edcio, as medidas da altura e espessura de mucosa ceratinizada (Exame cl\u00ednico \n\n2) foram novamente realizadas, seguindo o mesmo protocolo descrito anteriormente. \n\nForam tamb\u00e9m obtidas as tomadas radiogr\u00e1ficas finais do rebordo mandibular, \n\nbilateralmente. \n\n \n\nSeq\u00fc\u00eancia Laboratorial do Experimento \n\n As etapas laboratoriais seguiram a seguinte seq\u00fc\u00eancia: preparo das pe\u00e7as; \n\nconfec\u00e7\u00e3o das l\u00e2minas histol\u00f3gicas; an\u00e1lise histomorfom\u00e9trica, avalia\u00e7\u00e3o \n\nradiogr\u00e1fica e an\u00e1lise estat\u00edstica. \n\n \n\nPreparo das pe\u00e7as \n\n \n\nInicialmente, foi realizada a disseca\u00e7\u00e3o das mand\u00edbulas para remo\u00e7\u00e3o dos \n\nblocos \u00f3sseos e dos tecidos circunvizinhos envolvidos na pesquisa . Em seguida, \n\ncada bloco \u00f3sseo foi seccionado ao meio, tendo como refer\u00eancia os parafusos de \n\ntit\u00e2nio que foram fixados nas extremidades mesial e distal de cada defeito \u00f3sseo. A \n\nmetade mesial do bloco \u00f3sseo foi destinada para preparo de corte descalcificado. \n\n\n\n 41\n\nPara tal, primeiramente foram fixadas em solu\u00e7\u00e3o de formalina tamponada a 10% \n\n(pH 7) por 48 horas e, em seguida, lavadas em \u00e1gua corrente. Na seq\u00fc\u00eancia, foram \n\ndescalcificadas em banhos m\u00faltiplos de \u00e1cido tricloroac\u00e9tico a 10% por cerca de 60 \n\ndias e neutralizadas com solu\u00e7\u00e3o de sulfato de s\u00f3dio a 5%; posteriormente, as pe\u00e7as \n\nforam desidratadas em concentra\u00e7\u00f5es crescentes de \u00e1lcool a 70% (durante a noite), \n\n80%, 85%, 90%, 95%, 100% e finalmente pela combina\u00e7\u00e3o de \u00e1lcool mais xilol. Em \n\nseguida, foram diafanizadas em xilol, com tr\u00eas trocas de solu\u00e7\u00e3o a cada duas horas \n\ne por fim, embebidas em parafina. \n\nA metade distal de cada bloco \u00f3sseo foi fixada em uma solu\u00e7\u00e3o a 4% de \n\nformalina (pH 7), por 10 dias e transferida para uma solu\u00e7\u00e3o de etanol a 70%. \n\nFuturamente esses esp\u00e9cimes ser\u00e3o preparados para corte n\u00e3o-descalcificado. \n\n \n\nConfec\u00e7\u00e3o das L\u00e2minas para An\u00e1lises Histol\u00f3gica e Histomorfom\u00e9trica \n\n \n\nAp\u00f3s o preparo das pe\u00e7as, com o aux\u00edlio de um micr\u00f3tomo\u2021\u2021, foram obtidos \n\ncortes semi-seriados, da metade mesial dos blocos \u00f3sseos. Estes cortes, de 6 \u00b5m \n\nde espessura cada, foram feitos no plano m\u00e9sio-distal e at\u00e9 que fosse atingido o \n\nparafuso de tit\u00e2nio, fixado na extremidade mesial do defeito \u00f3sseo.  \n\nAs l\u00e2minas foram coradas com hematoxilina e eosina (HE) ou tricr\u00f4mico de \n\nMallory (TM): a cada quinze l\u00e2minas, a primeira foi corada com HE, e a seguinte com \n\nTM (por exemplo, a primeira com HE e a segunda com TM, a d\u00e9cima quinta com HE \n\ne a d\u00e9cima sexta com TM, e assim sucessivamente). Desse modo, houve um \n\nintervalo de ao menos 84 \u00b5m entre dois cortes com mesma colora\u00e7\u00e3o. \n\n \n\n                                                 \n\u2021\u2021 Rotary Microtome HM 335 E, MICROM Laborger\u00e4te GmbH, Carl-Zeiss, Alemanha. \n\n\n\n 42\n\nAn\u00e1lise Histomorfom\u00e9trica \n\n \n\nNove cortes histol\u00f3gicos da metade mesial do defeito \u00f3sseo foram \n\nexaminados atrav\u00e9s de microscopia \u00f3ptica sob luz convencional e polarizada, a fim \n\nde avaliar os tecidos neoformados. Destes nove cortes, tr\u00eas correspondiam ao ter\u00e7o \n\ninicial (mais mesial) do defeito \u00f3sseo, tr\u00eas ao ter\u00e7o central e os outros tr\u00eas ao ter\u00e7o \n\nfinal (mais distal \u2013 pr\u00f3ximos \u00e0 por\u00e7\u00e3o mediana do defeito cir\u00fargico confeccionado) do \n\ndefeito. \n\nUma c\u00e2mera de v\u00eddeo\u00a7\u00a7, associada a um microsc\u00f3pio***, possibilitou a \n\nrealiza\u00e7\u00e3o das medidas histomorfom\u00e9tricas. As imagens visualizadas no microsc\u00f3pio \n\neram registradas pela c\u00e2mera, enviadas a um computador e processadas atrav\u00e9s de \n\num programa espec\u00edfico\u2020\u2020\u2020; em seguida, a histomorfometria foi realizada com o \n\naux\u00edlio do programa Image Tool\u2021\u2021\u2021. Foram obtidas medidas de \u00e1rea, em mil\u00edmetros \n\nquadrados (mm2), e medida linear em mil\u00edmetros (mm). Como medidas de \u00e1rea \n\nforam avaliadas a \u00e1rea de novos tecidos (ANT) e a \u00e1rea de novo osso (ANO) e como \n\nmedida linear a altura \u00f3ssea m\u00e1xima (AO) (dist\u00e2ncia entre o osso mais coronal e a \n\nbase do defeito \u2013 Figura 3). A densidade \u00f3ssea (DO) do osso neoformado tamb\u00e9m \n\nfoi analisada. Essa medida foi calculada e expressa em porcentagem, subtraindo-se \n\na \u00e1rea dos espa\u00e7os \u00f3sseos medulares da \u00e1rea total de nova forma\u00e7\u00e3o \u00f3ssea. \n\nTodos os par\u00e2metros histomorfom\u00e9tricos foram avaliados nos nove cortes e a \n\nm\u00e9dia destas medidas foi calculada, representando assim a medida do defeito \n\n\u00f3sseo.  \n\n \n\n                                                 \n\u00a7\u00a7 Leica DC300, Leica Microsystems Nussloch GmbH, Heidelberger, Nussloch, Alemanha. \n*** Leica DMLB, Leica Microsystems Nussloch GmbH, Heidelberger, Nussloch, Alemanha. \n\u2020\u2020\u2020 Leica IM 50, Leica Imaging Systems Ltd., Cambridge, Inglaterra. \n\u2021\u2021\u2021 UTHSCSA Image Tool for Windows, Version 3.00. \n\n\n\n 43\n\n \n\nFigura 3: N: Note ( marca\u00e7\u00e3o da base do defeito) ; AO: altura \u00f3ssea m\u00e1xima; ANT: \u00e1rea de novos \ntecidos; ANO: \u00e1rea de novo osso. \n\n \n\nAvalia\u00e7\u00e3o Radiogr\u00e1fica \n\n \n\nTodas as radiografias foram obtidas por um mesmo examinador, atrav\u00e9s de \n\num sensor digital de imagens\u00a7\u00a7\u00a7 (Figura 4A) e de um aparelho de RX digital****. O \n\ntempo de exposi\u00e7\u00e3o foi fixado em 0,35 segundos e foi utilizada a t\u00e9cnica do \n\nparalelismo. Para padroniza\u00e7\u00e3o das imagens, utilizou-se ainda um posicionador \n\nradiogr\u00e1fico\u2020\u2020\u2020\u2020 e um registro de mordida em silicona de condensa\u00e7\u00e3o\u2021\u2021\u2021\u2021, \n\npreviamente confeccionado para cada animal (Figura 4 B). \n\nCom o objetivo de identificar mudan\u00e7as \u00f3sseas, foi realizada a subtra\u00e7\u00e3o \n\ndigital nas imagens radiogr\u00e1ficas (IR) adquiridas, com o aux\u00edlio do programa \n                                                 \n\u00a7\u00a7\u00a7 RVG Trophy, Eastman Kodak Company, Rochester, NY, USA. \n**** Spectro 70X Seletronic (coluna m\u00f3vel), Dabi Atlante, RP, Brasil. \n\u2020\u2020\u2020\u2020 Rinn/ XCP filmholders and InSight\u00ae , Eastman Kodak Co., Rochester, NY, EUA. \n\u2021\u2021\u2021\u2021 Optosil\u00ae Comfort Putty, Heraeus Kulzer South America Ltda., SP, Brasil \n\n\n\n 44\n\nEmago\u00a3. Essa subtra\u00e7\u00e3o foi feita aos pares, sendo: IR inicial (Figura 4C) e IR 8 \n\nsemanas (Figura 4D) (Imagem I-8), IR inicial e IR 16 semanas (Figura 4E) (Imagem \n\nI-16) , IR 8 semanas e IR 16 semanas (Imagem 8-16) (Figura 4). Inicialmente, os \n\npares de imagens foram abertos e alinhados, utilizando-se para isso quatro pontos \n\nem comum entre as duas imagens. Em seguida, foi feita a subtra\u00e7\u00e3o linear entre os \n\npares de imagens e uma nova imagem, representativa da diferen\u00e7a entre elas, foi \n\nobtida 47. A partir dessas tr\u00eas novas imagens (I-8, I-16 e 8-16) (Figuras 4F, 4G e 4H), \n\nobtidas com a subtra\u00e7\u00e3o, foi avaliada a \u00e1rea radiogr\u00e1fica de novo osso (ANO-R), em \n\nmm2. A \u00e1rea radiogr\u00e1fica do defeito \u00f3sseo (ARD) foi mensurada, em mm2, na IR \n\ninicial. A partir das medidas de ARD e ANO-R foi calculado o PO-R em 8 semanas \n\n(PO-R 8) e em 16 semanas (PO-R 16). Tamb\u00e9m foi avaliada radiograficamente a \n\ndensidade \u00f3ssea (DO-R), analisada em n\u00edveis de cinza, a partir das imagens \n\nradiogr\u00e1ficas Inicial, 8 semanas e 16 semanas. Para an\u00e1lise da DO-R foram \n\ntra\u00e7adas em cada imagem duas linhas imagin\u00e1rias, uma horizontal e outra vertical, \n\ncom o objetivo de se encontrar o centro da imagem. A partir desse ponto central (C), \n\nforam determinados outros tr\u00eas pontos: um coronal ao ponto central (Co), outro \n\napical (A) ao ponto central e um ponto na base da mand\u00edbula, externo ao defeito \n\n\u00f3sseo, o qual serviu como controle (Cr). Em cada ponto, foi posicionado um \n\nquadrado de 16 pixels2 de \u00e1rea. A DO-R foi ent\u00e3o calculada nos quatro pontos, nos \n\nquadrados de \u00e1rea conhecida 48, sendo: DO-R-Co, DO-R-C, DO-R-A e DO-R-Cr. A \n\nDO-R total de cada imagem foi obtida pela m\u00e9dia entre as DO-R-Co, DO-R-C e DO-\n\nR-A. As medidas de ARD, ANO-R, DO-R e PO-R, em cada imagem, foram \n\nrealizadas com o aux\u00edlio do programa Image Tool \u00a5.  \n\n                                                 \n\u00a3 Emago \u00ae / Advanced 3.43 ,Oral DiagnosticSystems, Louwesweg, Amsterdam, Holanda. \n\u00a5 UTHSCSA Image Tool for Windows, Version 3.00. \n\n\n\n 45\n\n \n\n \n\n \n\nFigura 4: A: Sensor digital de imagens; B: Posicionador radiogr\u00e1fico e registro de mordida em silicona \nde condensa\u00e7\u00e3o; C: IR inicial; D: IR 8 semanas; E: IR 16 semanas; F: Imagem obtida com a \nsubtra\u00e7\u00e3o entre IR inicial e IR 8 semanas (I-8); G: Imagem obtida com a subtra\u00e7\u00e3o entre IR inicial e IR \n16 semanas (I-16); H: Imagem obtida com a subtra\u00e7\u00e3o entre IR 8 semanas e IR 16 semanas (8-16) \n\n \n\n\n\n 46\n\nAn\u00e1lise Estat\u00edstica \n\nSeis animais (n=6) foram utilizados como unidade experimental. Os dados \n\nquantitativos foram registrados como m\u00e9dia \u00b1 desvio padr\u00e3o. A ocorr\u00eancia ou n\u00e3o de \n\ndiferen\u00e7as estatisticamente significantes (p &lt;0,05) entre os GT e GC (inter-grupos), \n\nem rela\u00e7\u00e3o aos par\u00e2metros cl\u00ednicos, histomorfom\u00e9tricos, e radiogr\u00e1ficos, bem como \n\nas diferen\u00e7as intra-grupos para os par\u00e2metros cl\u00ednicos e radiogr\u00e1ficos foi avaliada \n\natrav\u00e9s de an\u00e1lise estat\u00edstica n\u00e3o param\u00e9trica, para duas amostras relacionadas \n\n(Wilcoxon Sing Rank Test), com aux\u00edlio do programa SPSS\u00a7\u00a7\u00a7\u00a7. \n\n \n\n                                                 \n\u00a7\u00a7\u00a7\u00a7 SPSS, version 10.0, SPSS, Chicago, IL. \n\n\n\n 47\n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\nResultados \n\n \n\n\n\n 48\n\nRESULTADOS \n\n \n\nResultados Cl\u00ednicos \n\nTodos os procedimentos cir\u00fargicos foram bem tolerados pelos animais e \n\nnenhuma complica\u00e7\u00e3o sist\u00eamica trans ou p\u00f3s-operat\u00f3ria foi observada. Contudo, em \n\ndois c\u00e3es da amostra (c\u00e3es 1 e 5), ocorreu exposi\u00e7\u00e3o da membrana. No c\u00e3o 1, dez \n\ndias ap\u00f3s a realiza\u00e7\u00e3o da cirurgia 2, foi observada abertura do retalho com grande \n\nexposi\u00e7\u00e3o, deslocamento e ruptura da membrana, tendo esta perdido as suas \n\nfun\u00e7\u00f5es de barreira f\u00edsica e manuten\u00e7\u00e3o de espa\u00e7o. Em fun\u00e7\u00e3o disso, esse animal \n\nfoi exclu\u00eddo da amostra avaliada, motivo pelo qual para todas as an\u00e1lises estat\u00edsticas \n\nfoi utilizado um \u201cn\u201d = 6. No c\u00e3o 5, por sua vez, uma semana ap\u00f3s a cirurgia 2, notou-\n\nse pequena deisc\u00eancia da ferida cir\u00fargica, com conseq\u00fcente exposi\u00e7\u00e3o da \n\nmembrana, sendo realizada sutura no local da exposi\u00e7\u00e3o. Dez dias ap\u00f3s, foi \n\nobservada nova pequena abertura do retalho, com degrada\u00e7\u00e3o parcial da membrana \n\nno local da exposi\u00e7\u00e3o - a parte exposta da membrana foi ent\u00e3o removida. Para \n\ncontrolar a contamina\u00e7\u00e3o da membrana, foi aplicado sobre a ferida digluconato de \n\nclorexidina a 0,12% e estabelecida antibioticoterapia sist\u00eamica, procedimento que se \n\nrepetiu diariamente nos pr\u00f3ximos quinze dias. No d\u00e9cimo quinto dia, o animal foi \n\nent\u00e3o novamente sedado e notou-se que a \u00e1rea previamente exposta estava \n\ntotalmente cicatrizada - dessa forma, esse c\u00e3o permaneceu na amostra estudada. \n\nN\u00e3o foram encontradas diferen\u00e7as estatisticamente significantes entre os \n\ngrupos em rela\u00e7\u00e3o \u00e0 AMQ-V, AMQ-L, EMQ-V, EMQ-O e EMQ-L no exame Cl\u00ednico 1 \n\n(Tabela 1), demonstrando a similaridade pr\u00e9-operat\u00f3ria entre GT e GC. No Exame \n\ncl\u00ednico 2, a compara\u00e7\u00e3o entre os grupos revelou diferen\u00e7a estatisticamente \n\nsignificante entre eles somente em rela\u00e7\u00e3o \u00e0 AMQ-V (p= 0.028), tendo o GT \n\napresentado m\u00e9dia de 3,21 \u00b1 0,85 e o GC m\u00e9dia de  4,41 \u00b1 1,05 (Tabela 1).  \n\n\n\n 49\n\nCompara\u00e7\u00f5es intra-grupos entre as medidas realizadas no exame cl\u00ednico 1 e \n\n2 demonstraram que ambos os grupos tiveram um aumento na EMQ e redu\u00e7\u00e3o na \n\nAMQ. No GT foram encontradas diferen\u00e7as estatisticamente significantes para a \n\nEMQ-L(p=0,027), AMQ-V (p=0,028) e AMQ-L(p=0,028). No GC,por sua vez, a \n\ndiferen\u00e7a estat\u00edstica foi significativa apenas na AMQ-L (p=0,028) (Tabela 2).  \n\n \n\nTabela 1. Compara\u00e7\u00f5es entre os grupos teste (GT) e controle (GC) das m\u00e9dias \n(mm) dos par\u00e2metros cl\u00ednicos nos exames 1 e 2.  \n\n GT GC   GT GC   \n\nPar\u00e2metros Exame 1 Exame 1 Valor de p \u2020 Exame 2 Exame 2 Valor de p \u2020 \n\nEMQ-V 1,27 \u00b1 0,53 1,28 \u00b1 0,53  0,916 1,75 \u00b1 0,36 2,14 \u00b1 0,72  0,173 \n\nEMQ-O 1,60 \u00b1 0,43 1,49 \u00b1 0,56  0,917 1,88 \u00b1 0,31 1,88 \u00b1 0,64  0,686 \n\nEMQ-L 0,97 \u00b1 0,17 1,01 \u00b1 0,28  0,752 1,44 \u00b1 0,24 1,22 \u00b1 0,66  0,60 \n\nAMQ-V 3,90 \u00b1 0,75 4,77 \u00b1 0,98  0,173 3,21 \u00b1 0,85 4,41 \u00b1 1,05   0,028* \nAMQ-L 6,78 \u00b1 1,63 6,98 \u00b1 0,65  1,0 5,19 \u00b1 1,55 4,19 \u00b1 1,55  0,249 \n\nEMQ-V: Espessura da mucosa queratinizada vestibular; EMQ-O: Espessura da mucosa \nqueratinizada oclusal; EMQ-L: Espessura da mucosa queratinizada lingual; AMQ-V: Altura \nda mucosa queratinizada por vestibular; AMQ-L: Altura da mucosa queratinizada por lingual. \n\u2020 Teste de Wilcoxon; \n* Diferen\u00e7a estatisticamente significante (p&lt;0,05). \n \n\nTabela 2. Compara\u00e7\u00f5es entre os exames 1 e 2 das m\u00e9dias (mm) dos \npar\u00e2metros cl\u00ednicos nos grupos teste e controle (compara\u00e7\u00f5es intra-grupos). \n\n Grupo Teste Grupo Controle \n\nPar\u00e2metros Exame 1 Exame 2 Valor de p \u2020 Exame 1 Exame 2 Valor de p \u2020 \n\nEMQ-V 1,27 \u00b1 0,53 1,75 \u00b1 0,36 0,075 1,28 \u00b1 0,53 2,14 \u00b1 0,72 0,075  \n\nEMQ-O 1,60 \u00b1 0,43 1,88 \u00b1 0,31 0,463  1,49 \u00b1 0,56 1,88 \u00b1 0,64 0,463 \n\nEMQ-L 0,97 \u00b1 0,17 1,44 \u00b1 0,24 0,027*  1,01 \u00b1 0,28 1,22 \u00b1 0,66 0,345 \n\nAMQ-V 3,90 \u00b1 0,75 3,21 \u00b1 0,85 0,028* 4,77 \u00b1 0,98 4,41 \u00b1 1,05 0,463 \n\nAMQ-L 6,78 \u00b1 1,63 5,19 \u00b1 1,55 0,028* 6,98 \u00b1 0,65 4,19 \u00b1 1,55   0,028* \nEMQ-V: Espessura da mucosa queratinizada vestibular; EMQ-O: Espessura da mucosa \nqueratinizada oclusal; EMQ-L: Espessura da mucosa queratinizada lingual; AMQ-V: Altura \nda mucosa queratinizada por vestibular; AMQ-L: Altura da mucosa queratinizada por lingual. \n\u2020 Teste de Wilcoxon; \n* Diferen\u00e7a estatisticamente significante (p&lt;0,05). \n\n\n\n 50\n\nResultados Histol\u00f3gicos \n\n Em ambos os grupos foram observadas lamelas conc\u00eantricas a canais de Havers, \n\nindicando a presen\u00e7a de osso lamelar (maduro, secund\u00e1rio) (Figura 5C) Eram tamb\u00e9m \n\nobservadas \u00e1reas de matriz \u00f3ssea exibindo aspectos de feixes col\u00e1genos em diferentes \n\ndire\u00e7\u00f5es, interpretadas como osso imaturo (woven bone) residual. Foi verificada a \n\npavimenta\u00e7\u00e3o de osteoblastos tanto na superf\u00edcie interna das lamelas quanto na \n\nsuperf\u00edcie externa do osso formado. Tamb\u00e9m p\u00f4de ser observada a presen\u00e7a de matriz \n\noste\u00f3ide em algumas \u00e1reas da superf\u00edcie externa do novo osso, lamelas \n\ninterrompidas/parcialmente reabsorvidas, indicando remodela\u00e7\u00e3o do osso maduro \n\nformado (Figura 5D) bem como de linhas incrementais no interior da matriz \u00f3ssea . \n\n Em dois s\u00edtios do GC, foram observados remanescentes da membrana \n\nabsorv\u00edvel Osseoquest (figura 5E) associada a uma m\u00ednima rea\u00e7\u00e3o inflamat\u00f3ria, \n\ncaracterizada pela presen\u00e7a de c\u00e9lulas gigantes multinucleadas tipo corpo estranho. \n\nAl\u00e9m disso, em um s\u00edtio do grupo controle, no qual houve exposi\u00e7\u00e3o da membrana \n\nno per\u00edodo p\u00f3s-operat\u00f3rio (c\u00e3o 5), foi observada pequena migra\u00e7\u00e3o de tecido \n\nconjuntivo para o interior do defeito \u00f3sseo (Figura 5F) \n\n \n\n\n\n 51\n\n \n\n \n\n \n\nFigura 5: Imagem histol\u00f3gica grupo controle; B: Imagem histol\u00f3gica grupo teste; C: Lamelas \nconc\u00eantricas indicando presen\u00e7a de osso lamelar; D: Lamelas interrompidas/parcialmente \nreabsorvidas, indicando remodela\u00e7\u00e3o do osso maduro formado; E: Remanescentes da membrana \nabsorv\u00edvel Osseoquest; F: Migra\u00e7\u00e3o de tecido conjuntivo para o interior do defeito \u00f3sseo. \n\n\n\n 52\n\nResultados Histomorfom\u00e9tricos \n\n N\u00e3o foram encontradas diferen\u00e7as estatisticamente significantes entre os \n\ngrupos para nenhum dos par\u00e2metros histomorfom\u00e9tricos avaliados (Wilcoxon Sing \n\nRank Test, p&lt;0,05) (Tabela 3). A m\u00e9dia da \u00e1rea de novos tecidos (ANT) no GT foi \n\nde 73,04 \u00b1 0,96 mm2 e no GC de 69,42 \u00b1 7,45 mm2 (p=0,114). A m\u00e9dia da \u00e1rea de \n\nnovo osso (ANO) foi de 42,05 \u00b1 5,37 mm2 para o Grupo Teste e de 43,96 \u00b1 9,26 mm2 \n\nno Grupo Controle (p=0, 917). A m\u00e9dia de ANO no GT correspondeu a 58,99 % e no \n\nGC a 61,00 % da ANT. Em rela\u00e7\u00e3o \u00e0 altura \u00f3ssea m\u00e1xima (AO), a m\u00e9dia do Grupo \n\nTeste foi de 7,21 \u00b1 0,80 mm e do Grupo Controle de 7,70 \u00b1 1,21 mm (p=0, 463). No \n\nGT a \u00e1rea de novo osso cortical (densidade \u00f3ssea \u2013 DO), correspondeu em m\u00e9dia a \n\n42,47% da ANO, enquanto no GC a densidade \u00f3ssea observada foi de 38,08% da \n\nANO (p=0,463). \n\n \n\nResultados Radiogr\u00e1ficos \n\n Radiograficamente, pode-se observar ap\u00f3s 8 e 16 semanas da Cirurgia 2, \n\numa imagem sugestiva de neoforma\u00e7\u00e3o \u00f3ssea, tanto no GT como no GC. \n\n Inicialmente, para se verificar a padroniza\u00e7\u00e3o entre as radiografias, foi \n\nrealizada uma an\u00e1lise estat\u00edstica (Friedman Test) entre a m\u00e9dia da DO-R-Cr nas \n\nradiografias inicial, 8 semanas e 16 semanas, em ambos os grupos. Essa an\u00e1lise \n\nconfirmou a padroniza\u00e7\u00e3o entre as imagens radiogr\u00e1ficas, n\u00e3o sendo verificada para \n\na DO-R Cr diferen\u00e7a estatisticamente significante entre elas (GT, p= 0,4437; GC, p= \n\n0,4378) \n\n Na IR inicial foi encontrada para o Grupo Teste uma m\u00e9dia de ARD de 125,18 \n\n\u00b1 18,36 mm2 e no Grupo Controle de 126,10 \u00b1 10,16 mm2, n\u00e3o havendo entre os \n\ngrupos diferen\u00e7a estat\u00edstica significante (p = 0,916). Na imagem subtra\u00edda entre IR \n\n\n\n 53\n\ninicial e IR 8 semanas foi encontrada uma m\u00e9dia de ANO-R para o GT de 98,43 \u00b1 \n\n24,33 mm2 e para o GC de 102,30 \u00b1 16,51mm2. As diferen\u00e7as entre os grupos n\u00e3o \n\nforam estatisticamente significantes (p= 0, 752). A porcentagem de preenchimento \n\n\u00f3sseo radiogr\u00e1fico (PO-R) ap\u00f3s 8 semanas da Cirurgia 2 foi para o Grupo Teste de \n\n78,41 \u00b1 11,06% e para o Grupo Controle de 79,42 \u00b1 7,58 %, n\u00e3o havendo \n\nsignificativa diferen\u00e7a entre eles (p=0,752). Na avalia\u00e7\u00e3o entre IR inicial e IR 16 \n\nsemanas, por sua vez, foi obtida uma m\u00e9dia de ANO-R no GT de 103,54 \u00b1 19,69 \n\nmm2 e no GC de 108,12 \u00b1 21,96 mm2. Da mesma forma, n\u00e3o foram encontradas \n\ndiferen\u00e7as estatisticamente significantes entre os grupos (p= 0, 599). O PO-R em 16 \n\nsemanas foi para o GT e o GC respectivamente de 83,38 \u00b1 7,85 % e 83,68 \u00b1 11,03 \n\n% (p= 0, 916). Todos esses dados est\u00e3o sintetizados na Tabela 3. Em ambos os \n\ngrupos, atrav\u00e9s da subtra\u00e7\u00e3o de imagens entre IR 8 semanas e IR 16 semanas, n\u00e3o \n\nhouve diferen\u00e7a radiogr\u00e1fica detect\u00e1vel. Desse modo, n\u00e3o foi poss\u00edvel calcular a \n\nANO-R. \n\n Em uma an\u00e1lise intra-grupo, tanto para o GT como para o GC, n\u00e3o foi notada \n\ndiferen\u00e7a estatisticamente significante entre a ANO-R inicial e ap\u00f3s 8 semanas e \n\nANO-R inicial e ap\u00f3s16 semanas, sendo p=0,115 para os dois grupos. \n\n Em rela\u00e7\u00e3o \u00e0 DO-R, na avalia\u00e7\u00e3o radiogr\u00e1fica de 8 semanas, a m\u00e9dia da DO-\n\nR total (m\u00e9dia entre DO-R-Co, DO-R-C e DO-R-A) no GT foi de 116,44 \u00b1 16,37 e no \n\nGC de 119,77 \u00b1 26,88, n\u00e3o havendo diferen\u00e7a estat\u00edstica significativa entre os \n\ngrupos (p=0,463). Ap\u00f3s 16 semanas da Cirurgia 2, a m\u00e9dia desse mesmo par\u00e2metro \n\nsubiu para 129,11 \u00b1 15,70 no GT e para 125,77 \u00b1 13,35 no CG. A diferen\u00e7a entre os \n\ngrupos tamb\u00e9m n\u00e3o foi significativa estatisticamente, com p=0, 686. (Gr\u00e1fico 1) \n\n Avaliando-se separadamente a m\u00e9dia da DO-R em cada um dos pontos \n\nselecionados, ou seja, DO-R-Co, DO-R-C e DO-R-A, em 8 e 16 semanas, observou-\n\n\n\n 54\n\nse uma similaridade entre o GT e GC n\u00e3o sendo detectada diferen\u00e7a estat\u00edstica \n\nentre eles. (Tabela 4).  \n\n \n\nTabela 3. Compara\u00e7\u00f5es entre os grupos teste (GT) e controle (GC) das m\u00e9dias \nda ANO-R e da % de PO-R nos tempos de 8 e 16 semanas.  \n\n  8 semanas 16 semanas \n\n GT GC P\u2020 GT GC P\u2020 \n\nARD (mm2) 125,18 ? 18,36 126,10 \u00b1 10,16 0,91 125,18 \u00b1 18,36 126,10 \u00b1 10,16 0,91 \n\nANO-R (mm2) 98,43 \u00b1 24,33 102,30 \u00b1 16,51 0, 75 103,54 \u00b1 19,69 108,12 \u00b1 21,96 0,59 \n\n% PO-R 78,41 \u00b1 11,06 79,42 \u00b1 7,58 0,75 83,38 \u00b1 7,85 83,68 \u00b1 11,03 0, 91 \n\nARD: \u00e1rea radiogr\u00e1fica do defeito \u00f3sseo inicial; ANO-R : \u00e1rea radiogr\u00e1fica de novo osso; % PO-R : \nporcentagem de preenchimento \u00f3sseo radiogr\u00e1fico \n\u2020 Teste de Wilcoxon; \n\n \n\n \n\nDO-R\n\n0\n20\n40\n60\n80\n\n100\n120\n140\n160\n\n8 GT 8 GC 16 GT 16 GC\n\nGrupos\n\nN\n\u00edv\n\nei\ns \n\nde\n C\n\nin\nza\n\n \nDO-R: densidade \u00f3ssea radiogr\u00e1fica \n\n \nGr\u00e1fico 1. Compara\u00e7\u00f5es entre os grupos teste (GT) e controle (GC) das m\u00e9dias \nda DO-R total , nos tempos de 8 e 16 semanas. \n\n\n\n 55\n\n \n\n \n\n \n\n \n\n \n\n \n\nTabela 4. Compara\u00e7\u00e3o entre os grupos teste (GT) e controle (GC) das m\u00e9dias \nda DO-R-Co, DO-R-C, DO-R-A em 8 e 16 semanas \n\n8 semanas DOR-Co DOR-C DO-RA \n\nGT 73,16 \u00b1 18,55 124,83 \u00b1 17,81 151,33 \u00b1 15,24 \n\nGC 73,16 \u00b1 24,84 131,66\u00b1 32,90 154,50 \u00b1 35,10 \n\nValor de P\u2020 0,917 0,6 0,917 \n\n16 semanas DOR-Co DOR-C DO-RA \n\nGT 93,50 \u00b1 22,73 137,16 \u00b1 17,92 156,66 \u00b1 18,29 \n\nGC 84,16 \u00b1 15,87 135,33 \u00b1 18,65 157,83 \u00b1 14,02 \n\nValor de P\u2020 0,08 0,893 0,893 \n\nDO-R-Co: Densidade \u00f3ssea radiogr\u00e1fica coronal; DO-R-C: Densidade \u00f3ssea radiogr\u00e1fica \ncentral; DO-R-A: Densidade \u00f3ssea radiogr\u00e1fica apical  \n\u2020 Teste de Wilcoxon. \nEstatisticamente significante p<0,05 \n\n \n\n \n\n \n\n \n\n\n\n 56\n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\nDiscuss\u00e3o \n\n \n\n\n\n 57\n\nDISCUSS\u00c3O \n\n \n\n A Regenera\u00e7\u00e3o \u00f3ssea guiada tem sido usada com sucesso no tratamento de \n\nv\u00e1rios tipos de defeitos \u00f3sseos. V\u00e1rios materiais, n\u00e3o-absorv\u00edveis e absorv\u00edveis, t\u00eam \n\nsido utilizados como membrana, apresentando resultados similares em rela\u00e7\u00e3o \u00e0 \n\nquantidade de neoforma\u00e7\u00e3o \u00f3ssea 24, 49-52. \n\n Em 1994, foi introduzida na Periodontia a Matriz D\u00e9rmica Acelular. Este \n\nbiomaterial derivado de pele humana foi inicialmente indicado para procedimentos \n\nmucogengivais como uma alternativa aos enxertos de epit\u00e9lio e tecido conjuntivo \n\naut\u00f3geno 40, 53-55. Assim a MDA passou a ser largamente utilizada nos \n\nprocedimentos para recobrimento radicular e corre\u00e7\u00e3o de tecido mole em rebordo, \n\ndemonstrando resultados positivos, sobretudo em rela\u00e7\u00e3o ao ganho de mucosa \n\nqueratinizada em espessura e altura 21, 42. Em fun\u00e7\u00e3o desses resultados e de suas \n\ncaracter\u00edsticas estruturais, foram realizados trabalhos utilizando a matriz d\u00e9rmica \n\nacelular nos procedimentos de ROG 17, 18, 42 19, 56 57. Dessa maneira, como uma \n\nalternativa \u00e0s membranas, a MDA foi utilizada na regenera\u00e7\u00e3o de alv\u00e9olos frescos, \n\nem associa\u00e7\u00e3o \u00e0 coloca\u00e7\u00e3o de implantes e nos procedimentos para preserva\u00e7\u00e3o de \n\nrebordo alveolar, demonstrando resultados satisfat\u00f3rios. Andrade et al. em 200745, \n\ncomprovaram a habilidade da MDA em atuar como uma membrana em \n\nprocedimentos de RTG. No entanto, nenhum estudo controlado e randomizado em \n\nROG havia sido realizado at\u00e9 o momento com o intuito de comprovar esses \n\nresultados cl\u00ednicos positivos e avaliar a quantidade e qualidade do tecido \u00f3sseo \n\nneoformado. \n\n Os resultados deste estudo demonstraram que a matriz d\u00e9rmica acelular foi \n\nefetiva na fun\u00e7\u00e3o de barreira em ROG, sendo capaz de manter o espa\u00e7o, excluir os \n\n\n\n 58\n\ntecidos gengivais, permitindo assim adequada neoforma\u00e7\u00e3o \u00f3ssea, com resultados \n\nsimilares aos obtidos com a membrana absorv\u00edvel de copol\u00edmeros de \u00e1cidos \n\npoliglic\u00f3lico e polil\u00e1tico e carbonato trimetileno. Os defeitos \u00f3sseos cirurgicamente \n\ncriados neste estudo tinham dimens\u00f5es cr\u00edticas (12x8x10mm), n\u00e3o sendo poss\u00edvel \n\nsua completa regenera\u00e7\u00e3o sem a utiliza\u00e7\u00e3o de uma barreira mec\u00e2nica, como \n\ndemonstrado por Schenk et al. em 199446. Esses autores verificaram que o grupo \n\ncontrole negativo exibiu uma cicatriza\u00e7\u00e3o \u00f3ssea incompleta, com defeito \u00f3sseo \n\npersistente, enquanto nos grupos teste, onde se utilizou membrana n\u00e3o-absorv\u00edvel \n\nde PTFE-e, foi notada uma melhor cicatriza\u00e7\u00e3o, com preenchimento \u00f3sseo \n\nsatisfat\u00f3rio, embora a regenera\u00e7\u00e3o \u00f3ssea n\u00e3o estivesse completa ap\u00f3s 16 semanas. \n\nBornstein et al. (2007)58, por sua vez, n\u00e3o notaram diferen\u00e7a entre o grupo controle \n\nnegativo e o grupo teste em rela\u00e7\u00e3o ao ganho \u00f3sseo quando utilizaram uma \n\nmembrana absorv\u00edvel de col\u00e1geno \u2013 ambos os grupos n\u00e3o apresentaram \n\nneoforma\u00e7\u00e3o \u00f3ssea significante. A an\u00e1lise histol\u00f3gica do presente estudo \n\nevidenciou, em ambos os grupos, ap\u00f3s o per\u00edodo de cicatriza\u00e7\u00e3o de 16 semanas, \n\num tecido \u00f3sseo maduro, com lamelas conc\u00eantricas a canais de Havers e exibindo \n\nregi\u00f5es de remodela\u00e7\u00e3o \u00f3ssea, sobretudo nas bordas do defeito, mas ainda com a \n\npresen\u00e7a de um osso trabecular em processo de forma\u00e7\u00e3o e osso imaturo residual \n\nde dimens\u00f5es variadas, como j\u00e1 observado em outros estudos 46, 58. Desta maneira, \n\ncomo sugerido por Schenk et al.(1994) e 23, talvez um tempo de cicatriza\u00e7\u00e3o \n\nsuperior a 4 meses seja necess\u00e1rio para que a regenera\u00e7\u00e3o \u00f3ssea esteja completa. \n\n Histomorfometricamente, os grupos apresentaram resultados similares. A \n\nquantidade de osso neoformado no grupo teste correspondeu a 58,99 % da \u00e1rea de \n\nnovos tecidos, enquanto no grupo controle essa porcentagem foi de 61%. Esses \n\nresultados s\u00e3o similares aos obtidos por Schenk et al (1994)46, que relatou que o \n\n\n\n 59\n\nosso ocupava 55% do volume do defeito no mesmo per\u00edodo de tempo. A m\u00e9dia da \n\n\u00e1rea de novo osso no grupo tratado com a MDA foi de 42,05 mm2 e no grupo que \n\nrecebeu a membrana essa \u00e1rea m\u00e9dia foi de 43,96 mm2, resultado numericamente \n\nsuperior ao relatado por Bornstein et al (2007)58 (39,09 mm2 de \u00e1rea de novo osso \n\nem defeitos tratados com uma membrana de col\u00e1geno experimental ap\u00f3s 4 meses \n\nde cicatriza\u00e7\u00e3o). A altura \u00f3ssea m\u00e1xima observada no GT e GC foi respectivamente \n\nde 7,21 mm e 7,70 mm 59, o que representa 90,12% e 96,25 % da altura do defeito \n\n\u00f3sseo cirurgicamente confeccionado. A porcentagem de tecido \u00f3sseo cortical ap\u00f3s 4 \n\nmeses de cicatriza\u00e7\u00e3o foi 42,47% do ANO no GT e 38,08% no GC (p=0,463), \n\ncorroborando os resultados de Schenk et al46., que encontraram aproximadamente \n\n38% de osso cortical. Jovanovic et al. (2007)23, por sua vez, relataram uma \n\ndensidade \u00f3ssea variando entre 50 e 57% nos s\u00edtios controle ou tratados com ROG.  \n\nAs radiografias de subtra\u00e7\u00e3o retratam como uma \u00e1rea mais radiopaca as \n\ndiferen\u00e7as entre duas tomadas radiogr\u00e1ficas. Em linguagem computacional, as \n\nimagens radiogr\u00e1ficas s\u00e3o constitu\u00eddas por pixels. Na subtra\u00e7\u00e3o radiogr\u00e1fica digital, \n\na subtra\u00e7\u00e3o de dois pixels iguais resultaria no valor 0, gerando uma imagem preta. \n\nPara que isso n\u00e3o ocorra, o sistema automaticamente adiciona a cada subtra\u00e7\u00e3o, \n\npixel a pixel, o valor 128, o que resulta em uma imagem com um tom de cinza \n\nm\u00e9dio. Para as \u00e1reas em que a subtra\u00e7\u00e3o dos pixels n\u00e3o for 0, o valor pode ser \n\nacima de 128, resultando em uma \u00e1rea mais clara, ou abaixo de 128, resultando em \n\numa \u00e1rea mais escura47, 60 Dessa forma, as \u00e1reas mais radiopacas nas radiografias \n\nde subtra\u00e7\u00e3o foram interpretadas como uma poss\u00edvel neoforma\u00e7\u00e3o \u00f3ssea. Assim, \n\nap\u00f3s 8 semanas o GT mostrou uma taxa de preenchimento \u00f3sseo de 78,41 % e o \n\nGC de 79,42 % em rela\u00e7\u00e3o \u00e0 \u00e1rea radiogr\u00e1fica inicial do defeito. J\u00e1 em 16 semanas \n\nde p\u00f3s-operat\u00f3rio a imagem subtra\u00edda sugeriu uma porcentagem de novo osso igual \n\n\n\n 60\n\na 83,38 % quando se utilizou a MDA e a 83,68 % no grupo em que a Osseoquest foi \n\nutilizada. Novamente, os grupos demonstraram uma similaridade de resultados n\u00e3o \n\nhavendo diferen\u00e7as estat\u00edsticas entre eles. Jovanovic et al 200723 relataram \n\ncompleto preenchimento \u00f3sseo radiogr\u00e1fico; no entanto, eles avaliaram imagens \n\nconvencionais e n\u00e3o de subtra\u00e7\u00e3o.  \n\nPara os dois grupos, observou-se um aumento significativo da m\u00e9dia dos \n\nn\u00edveis de cinza quando se comparou a radiografia inicial com as imagens de \n\navalia\u00e7\u00e3o de 8 e 16 semanas, o que poder ser interpretado como uma crescente \n\nforma\u00e7\u00e3o ou mineraliza\u00e7\u00e3o do tecido \u00f3sseo. Entretanto, n\u00e3o houve diferen\u00e7a \n\nestat\u00edstica entre os dois tempos p\u00f3s-operat\u00f3rios (8 e 16 semanas). Isso parece \n\nmostrar que a maior parte do ganho \u00f3sseo detect\u00e1vel radiograficamente ocorre nas \n\nprimeiras 8 semanas, n\u00e3o havendo mudan\u00e7as significativas no intervalo desse \n\nper\u00edodo at\u00e9 16 semanas. \n\nOs resultados cl\u00ednicos encontrados neste estudo foram similares em ambos \n\nos grupos. Tanto o GT como o GC apresentaram um aumento na espessura de \n\nmucosa queratinizada. No grupo teste foi notado um aumento significativo para EMQ \n\nlingual (p=0,027), fato que est\u00e1 de acordo com estudos anteriores que \n\ndemonstraram a capacidade da MDA em aumentar a espessura de mucosa 29, 53, 56, \n\n61-63 64. Em rela\u00e7\u00e3o \u00e0 altura de mucosa queratinizada, ambos os grupos \n\ndemonstraram redu\u00e7\u00e3o nesse par\u00e2metro. No GT foi notada redu\u00e7\u00e3o significativa na \n\nAMQ vestibular e lingual (p=0, 028 em ambas). No GC, por sua vez, a diferen\u00e7a \n\nentre antes e depois da ROG foi significativa apenas para AMQ lingual. Em ambos \n\nos grupos foi realizada uma divis\u00e3o do retalho apicalmente \u00e0 base do defeito \u00f3sseo \n\ncriado cirurgicamente, de modo a permitir o deslocamento passivo do retalho em \n\ndire\u00e7\u00e3o coronal, garantindo a cobertura total da MDA e da membrana. Devido ao \n\n\n\n 61\n\ndeslocamento coronal do retalho, a linha mucogengival ficou posicionada mais \n\ncoronalmente em rela\u00e7\u00e3o \u00e0 sua posi\u00e7\u00e3o original, fato que pode explicar uma certa \n\nredu\u00e7\u00e3o da altura de mucosa queratinizada em ambos os grupos. Sabe-se que a \n\nlinha mucogengival tende a voltar \u00e0 sua posi\u00e7\u00e3o original no per\u00edodo p\u00f3s-operat\u00f3rio65, \n\nentretanto, 4 meses parece ter sido um tempo insuficiente para que isso ocorresse. \n\nAl\u00e9m disso, esse per\u00edodo de cicatriza\u00e7\u00e3o de 4 meses pode ter sido insuficiente para \n\nque a MDA por si s\u00f3 proporcionasse um aumento da AMQ, fato que est\u00e1 de acordo \n\ncom o estudo de Souza et al (2008) 66 Estes autores, em procedimento de \n\nrecobrimento radicular, observaram que 6 e 12 meses n\u00e3o foi um tempo suficiente \n\npara se identificar um aumento significativo na altura de mucosa. Vale ressaltar \n\nainda, que no relato de caso de Novaes Jr e Souza (2001)17, a matriz d\u00e9rmica \n\nacelular foi propositalmente deixada exposta com o objetivo de se aumentar a \n\nlargura de mucosa queratinizada, procedimento n\u00e3o realizado neste estudo, onde a \n\nMDA foi totalmente recoberta. A literatura de fato mostra resultados divergentes em \n\nrela\u00e7\u00e3o \u00e0 altura de mucosa queratinizada ap\u00f3s a utiliza\u00e7\u00e3o da matriz d\u00e9rmica \n\nacelular 30, 63, 64, visto que este aumento \u00e9 dependente da migra\u00e7\u00e3o de c\u00e9lulas com \n\ncapacidade de estimular a diferencia\u00e7\u00e3o em mucosa queratinizada, o que \u00e9 vari\u00e1vel \n\nentre esp\u00e9cies e dentro de uma mesma esp\u00e9cie 53.  \n\nApesar da semelhan\u00e7a entre os grupos em todos os resultados apresentados \n\nneste estudo, p\u00f4de-se observar que o per\u00edodo p\u00f3s-operat\u00f3rio do grupo tratado com \n\na MDA foi mais satisfat\u00f3rio, livre de intercorr\u00eancias. No grupo controle, ocorreu \n\nexposi\u00e7\u00e3o da membrana em dois animais, sendo um deles exclu\u00eddo da amostra. No \n\nc\u00e3o que permaneceu no estudo, a contamina\u00e7\u00e3o da membrana foi controlada \n\nmediante a aplica\u00e7\u00e3o t\u00f3pica de digluconato de clorexidina e administra\u00e7\u00e3o sist\u00eamica \n\nde antibioticoterapia, como descrito por diversos autores em estudos em humanos37, \n\n\n\n 62\n\n38, 67. Clinicamente notou-se neste animal a degrada\u00e7\u00e3o da por\u00e7\u00e3o exposta da \n\nmembrana e histologicamente pequena migra\u00e7\u00e3o dos tecidos gengivais para o \n\ninterior do defeito \u00f3sseo, evidenciando que neste caso a membrana Osseoquest n\u00e3o \n\nexerceu adequadamente a fun\u00e7\u00e3o de barreira. Esses achados est\u00e3o de acordo com \n\nv\u00e1rios estudos que demonstraram que as membranas absorv\u00edveis, quando expostas \n\nna cavidade bucal, se degradam precocemente no per\u00edodo p\u00f3s-operat\u00f3rio 22, 68-70 \n\nEntretanto, essa intercorr\u00eancia no per\u00edodo de cicatriza\u00e7\u00e3o n\u00e3o se refletiu nos \n\nresultados finais do grupo controle \u2013 os resultados apresentados pelo animal em \n\nquest\u00e3o n\u00e3o diferiram substancialmente dos outros da amostra.  \n\nOs resultados cl\u00ednicos, histomorfom\u00e9tricos e radiogr\u00e1ficos obtidos neste \n\nestudo demonstram que a t\u00e9cnica de ROG foi efetiva em ambos os grupos (Matriz \n\nD\u00e9rmica Acelular e Membrana Absorv\u00edvel), n\u00e3o havendo diferen\u00e7a entre eles. Desse \n\nmodo, indicam que a matriz d\u00e9rmica acelular tem capacidade de atuar como barreira \n\nf\u00edsica na regenera\u00e7\u00e3o \u00f3ssea guiada. \n\n\n\n 63\n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\nConclus\u00e3o \n\n \n\n\n\n 64\n\nCONCLUS\u00c3O \n\n \n\n A MDA apresentou resultados qualitativos e quantitativos similares \u00e0 \n\nmembrana absorv\u00edvel de copol\u00edmeros de \u00e1cido polil\u00e1tico e poliglic\u00f3lico e carbonato \n\ntrimetileno quando avaliada, atrav\u00e9s de par\u00e2metros cl\u00ednicos, radiogr\u00e1ficos e \n\nhistomorfom\u00e9tricos na t\u00e9cnica de ROG, em defeitos \u00f3sseos de rebordo em c\u00e3es. \n\n\n\n 65\n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\nRefer\u00eancias Bibliogr\u00e1ficas \n\n \n\n\n\n 66\n\nREFER\u00caNCIAS BIBLIOGR\u00c1FICAS \n\n \n\n1. Seibert J, Nyman S. Localized ridge augmentation in dogs: a pilot study using \n\nmembranes and hydroxyapatite. Journal of periodontology 1990;61:157-165. \n\n2. Kostopoulos L, Karring T. Augmentation of the rat mandible using guided \n\ntissue regeneration. Clinical oral implants research 1994;5:75-82. \n\n3. Kostopoulos L, Karring T. Guided bone regeneration in mandibular defects in \n\nrats using a bioresorbable polymer. Clinical oral implants research 1994;5:66-\n\n74. \n\n4. Blanco J, Alonso A, Sanz M. Long-term results and survival rate of implants \n\ntreated with guided bone regeneration: a 5-year case series prospective study. \n\nClinical oral implants research 2005;16:294-301. \n\n5. Barcelos MJ, Novaes Junior AB, Conz MB, Harari ND, Vidigal Junior GM. \n\nDiagnosis and treatment of extraction sockets in preparation for implant \n\nplacement: report of three cases. Brazilian dental journal 2008;19:159-164. \n\n6. Dahlin C, Sennerby, L., Lekholm, U., Linde, A. &amp; Nyman, S.   . Generation of \n\nnew bone around titanium implants using a membrane technique: an \n\nexperimental study in rabbits. International Journal of Oral &amp; Maxillofacial \n\nImplants 1989;4:19\u201325. \n\n7. Buser D, Dula K, Belser U, Hirt HP, Berthold H. Localized ridge augmentation \n\nusing guided bone regeneration. 1. Surgical procedure in the maxilla. The \n\nInternational journal of periodontics &amp; restorative dentistry 1993;13:29-45. \n\n8. Mecall RA, Rosenfeld AL. Influence of residual ridge resorption patterns on \n\nfixture placement and tooth position, Part III: Presurgical assessment of ridge \n\n\n\n 67\n\naugmentation requirements. The International journal of periodontics &amp; \n\nrestorative dentistry 1996;16:322-337. \n\n9. Fiorellini JP, Nevins ML. Localized ridge augmentation/preservation. A \n\nsystematic review. Annals of periodontology / the American Academy of \n\nPeriodontology 2003;8:321-327. \n\n10. Chiapasco M, Zaniboni M, Boisco M. Augmentation procedures for the \n\nrehabilitation of deficient edentulous ridges with oral implants. Clinical oral \n\nimplants research 2006;17 Suppl 2:136-159. \n\n11. Moses O, Pitaru S, Artzi Z, Nemcovsky CE. Healing of dehiscence-type \n\ndefects in implants placed together with different barrier membranes: a \n\ncomparative clinical study. Clinical oral implants research 2005;16:210-219. \n\n12. Gottlow J, Nyman S, Karring T, Lindhe J. New attachment formation as the \n\nresult of controlled tissue regeneration. Journal of clinical periodontology \n\n1984;11:494-503. \n\n13. Buser D, Bragger U, Lang NP, Nyman S. Regeneration and enlargement of \n\njaw bone using guided tissue regeneration. Clinical oral implants research \n\n1990;1:22-32. \n\n14. Nevins MM, J.T. . Enhancement of the damaged edentulous ridge to receive \n\ndental implants: a combination of allograft and the Gore-Tex membrane. \n\nInternational Journal of Periodontics and Restorative Dentistry 1992 12:97\u2013\n\n111. \n\n15. Aslan M, Simsek G, Dayi E. Guided bone regeneration (GBR) on healing bone \n\ndefects: a histological study in rabbits. The journal of contemporary dental \n\npractice 2004;5:114-123. \n\n\n\n 68\n\n16. Caffesse RG, Mota LF, Quinones CR, Morrison EC. Clinical comparison of \n\nresorbable and non-resorbable barriers for guided periodontal tissue \n\nregeneration. Journal of clinical periodontology 1997;24:747-752. \n\n17. Novaes AB, Jr., Souza SL. Acellular dermal matrix graft as a membrane for \n\nguided bone regeneration: a case report. Implant Dent 2001;10:192-196. \n\n18. Novaes AB, Jr., Papalexiou V, Luczyszyn SM, Muglia VA, Souza SL, Taba \n\nJunior M. Immediate implant in extraction socket with acellular dermal matrix \n\ngraft and bioactive glass: a case report. Implant Dent 2002;11:343-348. \n\n19. Griffin TJ, Cheung WS, Hirayama H. Hard and soft tissue augmentation in \n\nimplant therapy using acellular dermal matrix. The International journal of \n\nperiodontics &amp; restorative dentistry 2004;24:352-361. \n\n20. Lindhe J PR, Berglundh T, Araujo M. . The effect of flap management and \n\nbioresorbable occlusive devices in GTR treatment of degree III furcation \n\ndefects. An experimental study in dogs. Journal of clinical periodontology \n\n1995;22:276-283. \n\n21. Barros RR, Novaes AB, Jr., Grisi MF, Souza SL, Taba M, Jr., Palioto DB. New \n\nsurgical approach for root coverage of localized gingival recession with \n\nacellular dermal matrix: a 12-month comparative clinical study. J Esthet Restor \n\nDent 2005;17:156-164; discussion 164. \n\n22. Machtei EE. The effect of membrane exposure on the outcome of regenerative \n\nprocedures in humans: a meta-analysis. Journal of periodontology \n\n2001;72:512-516. \n\n23. Jovanovic SA, Hunt DR, Bernard GW, Spiekermann H, Wozney JM, Wikesjo \n\nUM. Bone reconstruction following implantation of rhBMP-2 and guided bone \n\n\n\n 69\n\nregeneration in canine alveolar ridge defects. Clinical oral implants research \n\n2007;18:224-230. \n\n24. Trombelli L, Farina R, Marzola A, Itro A, Calura G. GBR and autogenous \n\ncortical bone particulate by bone scraper for alveolar ridge augmentation: a 2-\n\ncase report. The International journal of oral &amp; maxillofacial implants \n\n2008;23:111-116. \n\n25. Yoshinari N, Tohya T, Mori A, et al. Inflammatory cell population and bacterial \n\ncontamination of membranes used for guided tissue regenerative procedures. \n\nJournal of periodontology 1998;69:460-469. \n\n26. Stavropoulos A, Sculean A, Karring T. GTR treatment of intrabony defects with \n\nPLA/PGA copolymer or collagen bioresorbable membranes in combination \n\nwith deproteinized bovine bone (Bio-Oss). Clinical oral investigations \n\n2004;8:226-232. \n\n27. Hurzeler MB, Quinones CR, Caffesse RG, Schupbach P, Morrison EC. Guided \n\nperiodontal tissue regeneration in Class II furcation defects following treatment \n\nwith a synthetic bioabsorbable barrier. Journal of periodontology 1997;68:498-\n\n505. \n\n28. Giusto TJ. Bioactive glass and bioabsorbable membrane in the treatment of a \n\nmaxillary class II furcation defect: case report with 6-month re-entry. Compend \n\nContin Educ Dent 2005;26:41-42, 44, 46 passim; quiz 52-43. \n\n29. Aichelmann-Reidy ME, Yukna, R. A.,Evans, G. H.Nasr, H. F.,Mayer, E. T. \n\nClinical evaluation of acellular allograft dermis for the treatment of human \n\ngingival recession. Journal of periodontology 2001;72:998-1005. \n\n30. Novaes AB Jr GD, Molina GO, Souza SLS, Taba M Jr, Grisi MFM. \n\nComparative 6- month clinical study of a subepithelial connective tissue graft \n\n\n\n 70\n\nand acellular dermal matrix for the treatment of gingival recession. Journal of \n\nperiodontology 2001;72:1477-1484. \n\n31. Pontoriero R, Wennstrom J, Lindhe J. The use of barrier membranes and \n\nenamel matrix proteins in the treatment of angular bone defects. A prospective \n\ncontrolled clinical study. Journal of clinical periodontology 1999;26:833-840. \n\n32. Caffesse RG, Nasjleti CE, Morrison EC, Sanchez R. Guided tissue \n\nregeneration: comparison of bioabsorbable and non-bioabsorbable \n\nmembranes. Histologic and histometric study in dogs. Journal of \n\nperiodontology 1994;65:583-591. \n\n33. Newman MG. The role of infection and anti-infection treatment in regenerative \n\ntherapy. Journal of periodontology 1993;64:1166-1170. \n\n34. Nowzari H, Slots J. Microorganisms in polytetrafluoroethylene barrier \n\nmembranes for guided tissue regeneration. Journal of clinical periodontology \n\n1994;21:203-210. \n\n35. Rossa ML, Lima LA, Pustiglioni FE, et al. SEM analyses of bacterial \n\ncontamination of e-PTFE membranes and GTR clinical results. Journal of the \n\nInternational Academy of Periodontology 2006;8:115-124. \n\n36. Tonetti MS, Pini-Prato G, Cortellini P. Periodontal regeneration of human \n\nintrabony defects. IV. Determinants of healing response. Journal of \n\nperiodontology 1993;64:934-940. \n\n37. Villaca JH, Rodrigues DC, Novaes AB, Jr., Taba M, Jr., Souza SL, Grisi MF. \n\nRoot trunk concavities as a risk factor for regenerative procedures of class II \n\nfurcation lesions in humans. Journal of periodontology 2004;75:1493-1499. \n\n38. Simonpietri CJ, Novaes AB, Jr., Batista EL, Jr., Filho EJ. Guided tissue \n\nregeneration associated with bovine-derived anorganic bone in mandibular \n\n\n\n 71\n\nclass II furcation defects. 6-month results at re-entry. Journal of periodontology \n\n2000;71:904-911. \n\n39. Tal H. Subgingival acellular dermal matrix allograft for the treatment of gingival \n\nrecession: a case report. Journal of periodontology 1999;70:1118-1124. \n\n40. Novaes AB, Jr., Grisi DC, Molina GO, Souza SL, Taba M, Jr., Grisi MF. \n\nComparative 6-month clinical study of a subepithelial connective tissue graft \n\nand acellular dermal matrix graft for the treatment of gingival recession. \n\nJournal of periodontology 2001;72:1477-1484. \n\n41. Wei PC LL, Geivelis M, Lingen MW, Maddalozzo D. . Acellular dermal matrix \n\nallografts to achieve increased attached gingiva. Part 1. A clinical study. \n\nJournal of periodontology 2000;71 1297-1305. \n\n42. Batista EL, Jr., Batista FC, Novaes AB, Jr. Management of soft tissue ridge \n\ndeformities with acellular dermal matrix. Clinical approach and outcome after 6 \n\nmonths of treatment. Journal of periodontology 2001;72:265-273. \n\n43. Novaes AB, Jr., Pontes CC, Souza SL, Grisi MF, Taba M, Jr. The use of \n\nacellular dermal matrix allograft for the elimination of gingival melanin \n\npigmentation: case presentation with 2 years of follow-up. Pract Proced \n\nAesthet Dent 2002;14:619-623; quiz 624. \n\n44. Pontes AE, Pontes CC, Souza SL, Novaes AB, Jr., Grisi MF, Taba M, Jr. \n\nEvaluation of the efficacy of the acellular dermal matrix allograft with partial \n\nthickness flap in the elimination of gingival melanin pigmentation. A \n\ncomparative clinical study with 12 months of follow-up. J Esthet Restor Dent \n\n2006;18:135-143; discussion 143. \n\n45. de Andrade PF, de Souza SL, de Oliveira Macedo G, et al. Acellular dermal \n\nmatrix as a membrane for guided tissue regeneration in the treatment of Class \n\n\n\n 72\n\nII furcation lesions: a histometric and clinical study in dogs. Journal of \n\nperiodontology 2007;78:1288-1299. \n\n46. Schenk RK BD, Hardwick WR, Dahlin C. . Healing pattern of bone \n\nregeneration in membrane-protected defects: a histologic study in the canine \n\nmandible. The International journal of oral &amp; maxillofacial implants 1994;9:13-\n\n29. \n\n47. Bittar-Cortez JA, Passeri LA, Boscolo FN, Haiter-Neto F. Comparison of hard \n\ntissue density changes around implants assessed in digitized conventional \n\nradiographs and subtraction images. Clinical oral implants research \n\n2006;17:560-564. \n\n48. Hwang YJ, Fien MJ, Lee SS, et al. Effect of scaling and root planing on \n\nalveolar bone as measured by subtraction radiography. Journal of \n\nperiodontology 2008;79:1663-1669. \n\n49. Hockers T, Abensur D, Valentini P, Legrand R, Hammerle CH. The combined \n\nuse of bioresorbable membranes and xenografts or autografts in the treatment \n\nof bone defects around implants. A study in beagle dogs. Clinical oral implants \n\nresearch 1999;10:487-498. \n\n50. Polimeni G, Koo KT, Pringle GA, Agelan A, Safadi FF, Wikesjo UM. \n\nHistopathological observations of a polylactic acid-based device intended for \n\nguided bone/tissue regeneration. Clinical implant dentistry and related \n\nresearch 2008;10:99-105. \n\n51. Thomaidis V, Kazakos K, Lyras DN, et al. Comparative study of 5 different \n\nmembranes for guided bone regeneration of rabbit mandibular defects beyond \n\ncritical size. Med Sci Monit 2008;14:BR67-73. \n\n\n\n 73\n\n52. Schwarz F, Rothamel D, Herten M, et al. Immunohistochemical \n\ncharacterization of guided bone regeneration at a dehiscence-type defect \n\nusing different barrier membranes: an experimental study in dogs. Clinical oral \n\nimplants research 2008;19:402-415. \n\n53. Paolantonio M, Dolci M, Esposito P, et al. Subpedicle acellular dermal matrix \n\ngraft and autogenous connective tissue graft in the treatment of gingival \n\nrecessions: a comparative 1-year clinical study. Journal of periodontology \n\n2002;73:1299-1307. \n\n54. Yan JJ, Tsai AY, Wong MY, Hou LT. Comparison of acellular dermal graft and \n\npalatal autograft in the reconstruction of keratinized gingiva around dental \n\nimplants: a case report. The International journal of periodontics &amp; restorative \n\ndentistry 2006;26:287-292. \n\n55. Cummings LC, Kaldahl WB, Allen EP. Histologic evaluation of autogenous \n\nconnective tissue and acellular dermal matrix grafts in humans. Journal of \n\nperiodontology 2005;76:178-186. \n\n56. Fowler EB, Breault LG, Rebitski G. Ridge preservation utilizing an acellular \n\ndermal allograft and demineralized freeze-dried bone allograft: Part I. A report \n\nof 2 cases. Journal of periodontology 2000;71:1353-1359. \n\n57. Luczyszyn SM, Papalexiou V, Novaes AB, Jr., Grisi MF, Souza SL, Taba M, \n\nJr. Acellular dermal matrix and hydroxyapatite in prevention of ridge \n\ndeformities after tooth extraction. Implant Dent 2005;14:176-184. \n\n58. Bornstein MM, Bosshardt D, Buser D. Effect of two different bioabsorbable \n\ncollagen membranes on guided bone regeneration: a comparative \n\nhistomorphometric study in the dog mandible. Journal of periodontology \n\n2007;78:1943-1953. \n\n\n\n 74\n\n59. Kikuchi M, Koyama Y, Yamada T, et al. Development of guided bone \n\nregeneration membrane composed of beta-tricalcium phosphate and poly (L-\n\nlactide-co-glycolide-co-epsilon-caprolactone) composites. Biomaterials \n\n2004;25:5979-5986. \n\n60. Bittar-Cortez JA, Passeri LA, de Almeida SM, Haiter-Neto F. Comparison of \n\nperi-implant bone level assessment in digitized conventional radiographs and \n\ndigital subtraction images. Dento maxillo facial radiology 2006;35:258-262. \n\n61. Araujo MG, Berglundh T, Lindhe J. GTR treatment of degree III furcation \n\ndefects with 2 different resorbable barriers. An experimental study in dogs. \n\nJournal of clinical periodontology 1998;25:253-259. \n\n62. Mellonig JT, Nevins M, Sanchez R. Evaluation of a bioabsorbable physical \n\nbarrier for guided bone regeneration. Part II. Material and a bone replacement \n\ngraft. The International journal of periodontics &amp; restorative dentistry \n\n1998;18:129-137. \n\n63. Felipe ME, Andrade PF, Grisi MF, et al. Comparison of two surgical \n\nprocedures for use of the acellular dermal matrix graft in the treatment of \n\ngingival recessions: a randomized controlled clinical study. Journal of \n\nperiodontology 2007;78:1209-1217. \n\n64. Andrade PF, Felipe ME, Novaes AB, Jr., et al. Comparison between two \n\nsurgical techniques for root coverage with an acellular dermal matrix graft. \n\nJournal of clinical periodontology 2008;35:263-269. \n\n65. Ainamo A, Bergenholtz A, Hugoson A, Ainamo J. Location of the mucogingival \n\njunction 18 years after apically repositioned flap surgery. Journal of clinical \n\nperiodontology 1992;19:49-52. \n\n\n\n 75\n\n66. de Souza SL, Novaes AB, Jr., Grisi DC, Taba M, Jr., Grisi MF, de Andrade PF. \n\nComparative clinical study of a subepithelial connective tissue graft and \n\nacellular dermal matrix graft for the treatment of gingival recessions: six- to 12-\n\nmonth changes. Journal of the International Academy of Periodontology \n\n2008;10:87-94. \n\n67. dos Anjos B, Novaes AB, Jr., Meffert R, Barboza EP. Clinical comparison of \n\ncellulose and expanded polytetrafluoroethylene membranes in the treatment of \n\nclass II furcations in mandibular molars with 6-month re-entry. Journal of \n\nperiodontology 1998;69:454-459. \n\n68. Simion M, Misitano, U., Gionso, L. &amp; Salvato, A.  . Treatment of dehiscences \n\nand fenestrations around dental implants using resorbable and nonresorbable \n\nmembranes associated with bone autografts: a comparative clinical study. \n\nInternational Journal of Oral &amp; Maxillofacial Implants 1997;12:159\u2013167 \n\n69. Lorenzoni M, Pertl C, Polansky RA, Jakse N, Wegscheider WA. Evaluation of \n\nimplants placed with barrier membranes. A restrospective follow-up study up \n\nto five years. Clinical oral implants research 2002;13:274-280. \n\n70. Tal H, Kozlovsky A, Artzi Z, Nemcovsky CE, Moses O. Cross-linked and non-\n\ncross-linked collagen barrier membranes disintegrate following surgical \n\nexposure to the oral environment: a histological study in the cat. Clinical oral \n\nimplants research 2008;19:760-766. \n\n\n\n 76\n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\nArtigo em Ingl\u00eas\n\n\n\n 77\n\nAcellular dermal matrix as a barrier in guided bone regeneration: A clinical, \n\nradiographic and histomorphometric study in dogs.  \n\n \n\nGermana Jayme Borges* DDS, MSc \n\nS\u00e9rgio Lu\u00eds Scombatti de Souza* DDS, PhD \n\nArthur Bel\u00e9m Novaes J\u00fanior* DDS, PhD  \n\nM\u00e1rcio Fernando de Moraes Grisi* DDS, PhD \n\nDaniela Bazan Palioto* DDS, PhD \n\nM\u00e1rio Taba J\u00fanior* DDS, PhD \n\n \n\n*Department of Bucco-Maxillo-Facial Surgery and Traumatology and Periodontology, \n\nSchool of Dentistry of Ribeir\u00e3o Preto, University of S\u00e3o Paulo (USP), Ribeir\u00e3o Preto, \n\nSP, Brazil. \n\n \n\nFinancial support: FAPESP \n\nCorrespondence: Dr. S\u00e9rgio Lu\u00eds Scombatti de Souza, Departamento de Cirurgia e \n\nTraumatologia Buco-Maxilo-Facial e Periodontia, Faculdade de Odontologia de \n\nRibeir\u00e3o Preto, Universidade de S\u00e3o Paulo, Av. do Caf\u00e9, s/n, CEP 14040-904, \n\nRibeir\u00e3o Preto - SP - Brazil. \n\nE-mail: scombati@forp.usp.br (ok to print). \n\n \n\nShort running title: Acellular dermal matrix as membrane for GBR. \n\n\n\n 78\n\nAbstract  \n\n \n\nObjective: The purpose of this study was to evaluate the acellular dermal matrix \n\n(ADM) as membrane for guided bone regeneration (GBR), comparing it to a \n\nbioabsorbable membrane. \n\n Material and Methods: In six dogs, the mandibular premolars were extracted. After \n\n8 weeks, bone defects were surgically created bilaterally and the GBR was \n\nperformed. Each side was randomly assigned to the control group (CG: \n\nbioabsorbable membrane made of glycolide and lactide copolymer) or test group \n\n(TG: ADM as a membrane). Immediately following GBR, standardized digital X-Ray \n\nradiographs were taken, and were repeated at 8 and 16 weeks post-operatively. \n\nPreviously to the GBR and to euthanasia, clinical measurements of the width and \n\nthickness of the keratinized tissue (WKT and TKT, respectively) were performed. The \n\ndogs were sacrificed 16 weeks following GBR, and histomorphometric analysis was \n\nmade. Area measurements of new tissue and new bone, and linear measurements of \n\nbone height were performed. \n\nResults: There were no statistically significant differences between groups for any \n\nhistomorphometric measurement. Clinically, both groups showed an increase in the \n\nTKT and reduction program in the WKT. Radiographically, it could be observed an \n\nimage suggestive of new bone formation in both groups 8 and 16 weeks following \n\nGBR. \n\nConclusion: ADM acted as a mechanical barrier in GBR, with clinical, radiographic \n\nand histomorphometric results similar to those obtained with the bioabsorbable \n\nmembrane.  \n\n\n\n 79\n\nIntroduction \n\n \n\nGuided bone regeneration(GBR) has been used as a treatment for alveolar \n\nridge deformities, bone defects associated to implants and in prevention of ridge \n\ndeformities after tooth extraction (Seibert &amp; Nyman 1990, Buser, et al. 1993, Mecall &amp; \n\nRosenfeld 1996, Fiorellini &amp; Nevins 2003, Chiapasco, et al. 2006). A variety of \n\nbiocompatible materials, non-absorbable or absorbable, have been used as \n\nmembranes in GBR to inhibit the apical migration of the epithelium and penetration of \n\nthe gingival connective tissue from the flap, and thus allow the regeneration of the \n\nalveolar bone (Nevins 1992). The literature indicates that from a clinical and \n\nhistological stand point, similar results can be achieved in GBR, whether \n\nbioabsorbable or non-bioabsorbable barriers are applied (Novaes &amp; Souza 2001, \n\nNovaes, et al. 2002, Griffin, et al. 2004). However, the bioabsorbable membrane \n\ndoes not require a second surgery for its retrieval and it can be assumed that a \n\nsingle-step surgical procedure is more economical and comfortable for the patient. \n\nSeveral studies showed that exposed membranes may be heavily colonized by \n\nbacteria and that a negative relationship exists between bone formation and plaque \n\ncolonization of the barrier material(Nowzari &amp; Slots 1994, Rossa, et al. 2006) (Machtei \n\n2001). Thus, it an ideal barrier should be made of material less susceptible for \n\nmembrane exposure or that cannot be significantly colonized by periodontogenic \n\nbacteria, when exposed in the oral cavity. Furthermore, a membrane that could lead to \n\nan increase in width and thickness of the keratinized tissue could be an advantage. \n\nThe acellular dermal matrix (ADM), material obtained from human skin, has been \n\nused as a substitute for palatal connective tissue to increase the width of keratinized \n\ntissue around teeth or implants(de Andrade, et al. 2007) for the treatment of alveolar \n\n\n\n 80\n\nridge deformities(Batista, et al. 2001), for root coverage procedures (Aichelmann-Reidy \n\n2001, Novaes AB Jr 2001) and for the removal of melanic pigmentation(Pontes, et al. \n\n2006, Novaes, et al. 2002) Recently, Andrade et al. (2007)(de Andrade, de Souza, de \n\nOliveira Macedo, Novaes, de Moraes Grisi, Taba &amp; Palioto 2007), evaluated the ADM as \n\nmembrane for guided tissue regeneration (GTR) in the treatment of mandibular class II \n\nfurcation lesions, and compared it to a bioabsorbable membrane. In this study, the ADM \n\ndemonstrated similar histomorphometric results to the bioabsorbable membrane and \n\nresulted in an increase of the thickness of keratinized tissue greater than that showed by \n\nthe bioabsorbable membrane. Some clinical studies have also used the ADM as a \n\nmembrane for guided bone regeneration in edentulous ridges and in association with \n\nimmediate implants, suggesting that this material may be able to act as barrier(Novaes, \n\nPapalexiou, Luczyszyn, Muglia, Souza &amp; Taba Junior 2002, Griffin, Cheung &amp; Hirayama \n\n2004, Fowler, et al. 2000) However, animal controlled studies are necessary to evaluate \n\nthe ADM as membrane in GBR, comparing it to other membrane materials.  \n\nThe ADM is probably not significantly colonized by periodontogenic bacteria \n\nbecause when this material is exposed in the oral cavity, the healing is uneventful. \n\nThis would probably not occur if there was a significant bacterial colonization(Buser, \n\net al. 1990, Caffesse RG 1997). In addition, the ADM leads to an increase in width \n\nand thickness of the keratinized tissue after surgery as has been demonstrated by \n\nseveral studies (Seibert &amp; Nyman 1990, Lindhe J 1995, Novaes, et al. 2001). \n\nTo the best of our knowledge, there are no controlled studies using the ADM \n\nas membrane in the guided bone regeneration. The purpose of this study was to \n\nclinically, radiographicaly and histomorphometrically evaluate the use of acellular \n\ndermal matrix graft as a membrane for guided bone regeneration in the treatment of \n\nsurgically created bone defects in dogs, comparing it to a bioabsorbable membrane. \n\n\n\n 81\n\nMaterial and Methods \n\n The study protocol was approved by the Ethics Committee for Animal Use of \n\nthe University of S\u00e3o Paulo (USP) \u2013 Ribeir\u00e3o Preto  \n\n \n\nSurgical Sequence \n\n This study had the following experimental steps: Animal selection and \n\npreparation, Surgery 1 (extraction of P1, P2, P3 and P4, mandibular pre-molars, \n\nwhich created and edentulous space of approximately 50mm); 6 weeks later, the \n\nkeratinized tissue was evaluated (Clinical Exam 1); 2 weeks later, Surgery 2 was \n\ncarried out (rectangular bilateral bone defects were prepared, absorbable \n\nmembrane***** and acellular dermal matrix\u2020\u2020\u2020\u2020\u2020 were applied); control radiographic \n\nevaluation 8 weeks following surgery 2; second keratinized tissue evaluation (Clinical \n\nExam 2), final radiographic evaluation and sacrifice of the animals (16 weeks \n\nfollowing Surgery 2).  \n\nAnimal selection and preparation \n\n Seven young male dogs mongrel dogs were selected weighting from 25 to \n\n35kg. The animals presented intact superior and inferior teeth, no viral or fungal oral \n\nlesions, no periodontal disease and were in good general health, with no systemic \n\ninvolvement, as determined by a veterinarian following clinical examination. The dogs \n\nreceived antiparasitary treatment, multivitamins, a complete series of vaccines and \n\nprophylactic treatment with ultrasonic instruments\u2021\u2021\u2021\u2021\u2021. All prophylactic treatment and \n\nsurgical procedures were carried out after the animals had been anesthetized. \n\nSurgery 1 \u2013 Bilateral extraction of all 4 mandibular pre-molars  \n\n                                                 \n***** Osseoquest, Gore and Associates, Inc., Flagstaff, Arizona, E.U.A. \n\u2020\u2020\u2020\u2020\u2020  Alloderm, Life Cell Corporation, New Jersey, EUA. \n\u2021\u2021\u2021\u2021\u2021 Cavitron 3000, Dentsply Mfg. Co., York, PA, E.U.A. \n\n\n\n 82\n\n The animals were not fed the night prior to the surgical procedure. They were \n\npre-anesthetized with Zolazepan at 0.10mL/kg and Acepromazine at 0.10mL/kg. \n\nAnesthesia was maintained with the oxygen-diluted volatile anesthetic Isoflurane? \n\nuntil the surgical procedure was concluded. \n\nFollowing anesthesia, mucoperiosteal flaps were released bilaterally in the \n\nregion of the 4 inferior pre-molars. The teeth were sectioned in the buccal-lingual \n\ndirection at the furcation, and the roots were individually extracted using a periotome \n\nin order to not damage the bone walls. The flaps were then repositioned and sutured \n\nwith absorbable sutures. \n\nAnimals were fed only with water-softened dog food to prevent rupture of the \n\nsuture for 14 days. Healing evaluation control was performed weekly In addition, by \n\ntopical application of 0.12% chlorhexidine. \n\nClinical analysis of keratinized tissue \n\n Six weeks after Surgery 1, clinical measurements (Clinical Exam 1) were \n\nmade to evaluate the thickness and width of keratinized tissue (TKT and WKT \n\nrespectively). A custom-made acetate stent extending from canine to molar teeth was \n\nused to determine the exact site for the measurements. Three reference marks in the \n\narea corresponding to the bone defect were made in the stent: one vestibular, one \n\nocclusal and one lingual. All clinical measurements were taken by the same operator. \n\nThe WKT was measured in the buccal (B-WKT) and lingual (L-WKT) surfaces, \n\ncorresponding, respectively, to the distance between a reference mark on the \n\nocclusal face and the vestibular or lingual mucogingival junction (MGJ). The \n\nmeasurements were taken using a compass and transferred to a slide caliper  \n\n                                                 \n? Isoflurano, Instituto Bioch\u00edmico, Atibaia-SP. \n\n\n\n 83\n\nThe TKT was performed at the buccal (B-TKT), occlusal (O-TKT) and lingual \n\n(L-TKT) surfaces, in the corresponding markings of the guide. These measurements \n\nwere taken using a periodontal probe associated to a silicone disk stop. The probe \n\nwas positioned perpendicularly to the keratinized tissue surface and introduced into \n\nthe soft tissue with light pressure until a hard surface was felt. The silicone disk stop \n\nwas then placed in tight contact with the external soft tissue surface. After carefully \n\nremoving the periodontal probe, penetration depth was measured with a slide caliper \n\nThe measurements of B-TKT, O-TKT and L-TKT were taken three times and the \n\nmean value was calculated for each site.  \n\nSurgery 2 - Bone defects creation and GBR \n\nEight weeks after tooth extraction, the animals underwent the second surgical \n\nprocedure (Surgery 2). After repeating the same sedation and anesthesia described \n\nfor Surgery 1, horizontal crestal incisions were bilaterally made from the distal region \n\nof the canine to the mesial region of the first molar to gain access to the alveolar \n\nridge, and a mucoperiosteal flap was raised buccally and lingually, exposing the \n\nalveolar ridge. One rectangular bone defect was surgically created bilaterally in the \n\narea of the previously extracted premolars, using low-speed rotary burs and hand \n\ninstruments. Copious sterile saline irrigation was used during preparation of the bone \n\ndefects. Defect dimensions were 8 mm apico-coronal, 12 mm mesio-distal, and 10 \n\nmm bucco-lingual, measurements that comprise a critical defect (Schenk RK 1994). \n\nIn the mesial and distal edges of each defect, 3mm from the base, a titanium screw \n\nwas attached to serve as a landmark for locating the defect areas radiographically \n\nand during the histological preparation of the specimens. \n\n In one side of the mandible, randomly assigned by a coin toss, the defect was \n\ncovered by a bioabsorbable membrane (Osseoquest), comprising the Control Group \n\n\n\n 84\n\n(CG). The membrane was trimmed to shape, adapted over the ridge to completely \n\ncover the defect, and extended beyond the defect margins by 2 to 3 mm. The \n\nmembrane was kept in position by the attached titanium screws in the buccal and \n\nlingual walls. Subsequently, the flap was repositioned and sutured with horizontal \n\nand interrupted e-PTFE sutures, so the membrane would be completely covered and \n\nprotected. On the opposite hemiarch, the acellular dermal matrix was adapted on the \n\nbone defect following the same sequence described for the membrane, and was \n\nselected for the Test Group (TG). After placing the acellular dermal matrix and \n\nsuturing the flaps to completely cover the ADM, standardized digital radiographs of \n\nbone defects were obtained, bilaterally, with a digital imaging sensor\u00a7\u00a7\u00a7\u00a7\u00a7  \n\nPost-operatory treatment \n\nTramadol Chloridrate (50mg/mL)****** was used at 3mg/kg every 12 hours as \n\nanalgesic therapy and Ketofen\u2122 20? at 1 pill/20kg was used as anti-inflammatory \n\ntherapy. The animals also received Espiramicine? at 1pill/10kg for 10 days as \n\nantibiotic therapy. The animals were maintained on a soft ration diet for 15 days, and \n\nthen the sutures were removed. Healing control was performed daily with topical \n\napplication of 0.12% chlorhexidine to limit biofilm production. The remained teeth \n\nwere cleaned monthly with ultrasonic points  \n\nRadiographic Evaluation \n\n Eight weeks after Surgery 2, the animals were sedated as previously \n\ndescribed and radiographs of the bone defects were obtained following the same \n\ndescribed procedures.  \n\nSacrifice of the animals  \n\n                                                 \n\u00a7\u00a7\u00a7\u00a7\u00a7 Trophy system (Trophy-Radiologie, Vincennes, France).  \n******Tramal\u00ae, Laborat\u00f3rios Pfizer Ltda, S\u00e3o Paulo,sp. \n? Ketofen, Merial Sa\u00fade Animal Ltda, Paul\u00ednia, SP. \n? Stomorgyl 10, Merial Sa\u00fade Animal Ltda, Paul\u00ednia, SP. \n\n\n\n 85\n\n Sixteen weeks following Surgery 2, the animals were sacrificed, by induction \n\nof deep anesthesia with subsequent intravenous sodium thiopental and potassium \n\nchloride overdose. Before the sacrifice, measurements of width and thickness of \n\nkeratinized tissue were again taken (Clinical Exam 2) following the same protocol as \n\npreviously described. Radiographs were also taken bilaterally from the mandibular \n\nridge. \n\nHistological preparation \n\n After euthanasia, the mandibles were dissected and the block sections \n\ncontaining the experimental specimens were obtained. Subsequently, each bone \n\nblock was sectioned in half, considering as reference the titanium screws attached in \n\nthe mesial and distal edges of bone defect. The mesial halves were prepared for \n\ndecalcified sectioning. Thus, they were fixed in a 10% formalin solution and \n\ndecalcified in multiple baths of 10% trichloricacetic acid for approximately 60 days \n\nand neutralized using a 5% sodium sulfate solution. After decalcification and \n\ndehydration, the blocks were immersed in paraffin, and semi-serial 6-\u00b5m wide \n\nbuccal-lingual histological sections were obtained from the mesial half of the bone \n\nblocks using a microtome\u2020\u2020\u2020\u2020\u2020\u2020. These histological sections were stained either with \n\nhematoxylin-eosin (HE) or Mallory's trichrome stain (MT). \n\nHistomorphometric analysis  \n\nNine non-serial histological sections of the mesial half of the bone defect were \n\nanalyzed under conventional and polarized light microscopy in order to evaluate \n\nnewly-formed tissues. Among these 9 sections, three belonged to the initial third of \n\nthe defect (mesial area), three belonged to the middle third of the defect and the \n\nremaining three belonged to the final third of the defect (distal area). \n\n                                                 \n\u2020\u2020\u2020\u2020\u2020\u2020 Rotary Microtome HM 335 E, MICROM Laborger\u00e4te GmbH, Carl-Zeiss, Alemanha. \n\n\n\n 86\n\nA video camera\u2021\u2021\u2021\u2021\u2021\u2021 attached to a microscope\u00a7\u00a7\u00a7\u00a7\u00a7\u00a7 allowed \n\nhistomorphometric measurements. The images were processed with Leica IM \n\n50*******. Histomorphometric analysis was then performed using the software Image \n\nTool\u2020\u2020\u2020\u2020\u2020\u2020\u2020, with area, in square millimeters (mm2), and linear, in millimeters (mm), \n\nmeasurements. Area measurements assessed were: area of new tissues (ANT) and \n\narea of new bone (ANB). Linear measurement was the maximum bone height (BH) \n\n(distance between the most coronally-formed bone and the base of the defect). The \n\nbone density, expressing the cortical bone area (CBA), was also measured, by the \n\nsubtraction of the new bone marrow area from the new bone area, and expressed in \n\npercentage. All histomorphometric parameters were analyzed in the nine sections \n\nand arithmetic average was calculated, thus representing the measure of the bone \n\ndefect. \n\nRadiographic analysis  \n\nAll radiographs were acquired by a single examiner, using a digital imaging \n\nsensor\u2021\u2021\u2021\u2021\u2021\u2021\u2021 and a digital X-Ray unit\u00a7\u00a7\u00a7\u00a7\u00a7\u00a7\u00a7. Exposure time was set to 0.35 seconds \n\nand paralleling technique was used. To standardize the geometry, an individual \n\nsilicone******** made bite-block with occlusal registration was used, for each animal. \n\nTo evaluate bone changes, the digital subtraction of images was performed by \n\nusing Emago\u00a3 software. The subtraction was calculated in pairs, as follows: initial RI and \n\n8 week RI (I-8 image), initial RI and 16 week RI (I-16 image), 8 week RI and 16 week RI \n\n(8-16 image). A new image representing the difference between the two previous \n\nimages was obtained (I-8, I-16 and 8-16)(Bittar-Cortez, et al. 2006). From these three \n\n                                                 \n\u2021\u2021\u2021\u2021\u2021\u2021 Leica DC300, Leica Microsystems Nussloch GmbH, Heidelberger, Nussloch, Alemanha. \n\u00a7\u00a7\u00a7\u00a7\u00a7\u00a7 Leica DMLB, Leica Microsystems Nussloch GmbH, Heidelberger, Nussloch, Alemanha. \n******* Leica IM 50, Leica Imaging Systems Ltd., Cambridge, Inglaterra. \n\u2020\u2020\u2020\u2020\u2020\u2020\u2020 UTHSCSA Image Tool for Windows, Version 3.00. \n\u2021\u2021\u2021\u2021\u2021\u2021\u2021 RVG Trophy, Eastman Kodak Company, Rochester, NY, USA. \n\u00a7\u00a7\u00a7\u00a7\u00a7\u00a7\u00a7 Spectro 70X Seletronic, Dabi Atlante, RP, Brasil. \n******** Optosil\u00ae Comfort Putty, Heraeus Kulzer South America Ltda., SP, Brasil \n\u00a3 Emago \u00ae / Advanced 3.43 ,Oral DiagnosticSystems, Louwesweg, Amsterdam, Holanda. \n\n\n\n 87\n\nnew subtraction-obtained images, the radiographic area of new bone (ANB-R) was \n\nmeasured in mm\u00b2. The radiographic area of bone defect (ABD-R) was measured in mm2 \n\nfrom initial RI. The radiographic bone fill (BF-R) was calculated in 8 weeks (BF-R 8) and \n\n16 weeks (BF-R 16), as the ratio ANB-R/ABD-R, and expressed in percentage values. \n\nThe bone density was also radiographically evaluated (BD-R) in grayscale, in the \n\nradiographs taken at Initial time, 8 weeks time and 16 weeks time. To analyze BD-R, two \n\nlines were drawn (a vertical and an horizontal one), to determine the central point of the \n\nimage. From this central point (C), three others standardized regions of interest were \n\ndefined: a coronal one to the central point (Co), an apical one to the central point (A) and \n\nanother one at the base of the mandible, external to the bone defect, which served as \n\nControl (Cr). On these standardized regions, a 16 pixels\u00b2 square was positioned and the \n\nBD-R was then calculated in these squares of known area(Hwang, et al. 2008), \n\ncomprising: BD-R-Co, BD-R-C, BD-R-A, BD-R-Cr. Total BD-R of each image was \n\nobtained with the arithmetic average from BD-R-Co, BD-R-C and BD-R-A. BD-R-Cr was \n\nused as a control region and was not expected to demonstrate changes in radiographic \n\ndensity during the study. The measurements of ANB-R, BF-R and BD-R were obtained \n\nwith Image Tool software\u00a5. \n\nStatistical Analysis \n\nThe experimental unit was the animal (n=6). Quantitative data were recorded \n\nas mean \u00b1 standard deviation (SD). A non-parametric statistical analysis for two \n\nrelated sample groups, the Wilcoxon Sing Rank Test (n=6; P&lt;0.05), was carried out \n\nto determine clinical, radiographic and histomorphometric differences between TG \n\nand CG (inter-groups), as well as the intra-group differences for the clinical (WKT and \n\nTKT) and radiographic parameters, using SPSS\u2020\u2020\u2020\u2020\u2020\u2020\u2020\u2020 software  \n\n                                                 \n\u00a5 UTHSCSA Image Tool for Windows, Version 3.00. \n\u2020\u2020\u2020\u2020\u2020\u2020\u2020\u2020 SPSS, version 10.0, SPSS, Chicago, IL. \n\n\n\n 88\n\nResults \n\n \n\nClinical Results \n\nAll surgical procedures were well tolerated by the animals and no signs of \n\ninfection were observed. However, in two dogs, there was exposure of the \n\nabsorbable membrane. In one dog, one week after GBR, the flap opened leading to a \n\ndisplacement and rupture of the membrane, which lost its functions as a physical \n\nbarrier and space maintainer. Therefore, this animal was excluded from the study. In \n\nanother dog, two weeks following surgery, a discrete dehiscence in the surgical \n\nwound was noticed, with consequent exposure of the membrane. Approximately one \n\nmonth after the surgery of GBR, the exposed portion of this membrane was \n\ncompletely degraded, and the previously exposed area had completely healed. \n\nNo statistically significant differences were observed between groups for B-\n\nWKT, L-WKT, B-TKT, O-TKT and L-TKT in Clinical Exam 1 (Table 1), demonstrating \n\npre-operatory similarity between TG and CG. In Clinical Exam 2, the comparison \n\nbetween groups revealed statistically significant differences only for B-WKT (p= \n\n0.028), with TG showing a mean value of 3.21 \u00b1 0.85 and CG a mean value of 4.41 \u00b1 \n\n1.05 (Table 1). \n\nIntra-group comparisons between the measurements of Clinical Exam 1 and 2 \n\nshowed that both groups had an increase in TKT and reduction in WKT. In the TG, \n\nstatistically significant differences were found for L-TKT (p=0.027), B-WKT (p=0.028) \n\nand L-WKT (p=0.028). In the CG there was statistically significant difference only for \n\nL-WKT (p=0.028) (Table 2). \n\n \n\n \n\n\n\n 89\n\nHistological Evaluation \n\nIn both groups, concentric lamellar structures and haversian canals were \n\nobserved, suggesting the presence of lamellar (mature and secondary) bone. Areas \n\nof bone matrix containing collagen fibers projected in several directions were also \n\nobserved. Such areas were interpreted as residual immature (woven) bone. The \n\ninternal surface of the lamellae and external surface were lined with osteoblast-like \n\ncells. An osteoid matrix was also identified in some areas in the external surface of \n\nthe newly-formed bone; interrupted/partially resorbed lamellae and incremental lines \n\nwere frequently observed in the newly formed bone, indicating regions of new bone \n\nformation. \n\nIn two sites of the CG, the presence of small remnants of the bioabsorbable \n\nmembranes was found, which was associated with a minimal inflammatory reaction \n\nand the presence of scattered foreign-body giant cells . Furthermore, in a site from \n\nthe control group, in which there was exposure of the membrane during the post-\n\noperatory period, downgrowth of connective tissue towards the interior of the bone \n\ndefect was observed. \n\nHistomorphometric Results  \n\nNo statistically significant differences between groups were found for any \n\nhistomorphometric measurement (Wilcoxon Sing Rank Test, p&lt;0.05). The mean \n\nvalue for area of new tissues (ANT) was 73.04 \u00b1 0.96 mm2 for TG and 69.42 \u00b1 7.45 \n\nmm2 for CG (p=0,114); the mean area of new bone (ANB) was 43.96 \u00b1 9.26mm\u00b2 for \n\nCG and 42.05 \u00b1 5.37mm\u00b2 for TG (p=0.917). For bone height (BH), the mean value for \n\nCG was 7.70 \u00b1 1.21mm, and for TG, it was 7.21 \u00b1 0.80 (p=0.463). In CG, the cortical \n\nbone area (CBA) corresponded on average to 38.08% of the ANB, while in TG, it was \n\n42.47% of the ANB (p=0.463). \n\n\n\n 90\n\nRadiographic Results \n\nThe statistical analysis (Friedman Test) between the mean values of BD-R-Cr \n\nobtained at initial radiograph image, at 8 weeks and 16 weeks post-operatively, for \n\nboth groups, confirmed that the images were well standardized, since no statistically \n\nsignificant differences were found for this parameter among the radiographic images \n\n(TG, p= 0.444; CG, p= 0.438). \n\nIn the initial RI, the mean values of ABD-R for the Test Group was 125.18 \u00b1 \n\n18.36 mm2 and for the Control Group was 126.10 \u00b1 10.16 mm2, with no statistical \n\ndifference between the groups (p = 0916). \n\nRadiographically, it could be observed an image suggestive of new bone \n\nformation in both groups 8 and 16 weeks following GBR. \n\nIn the subtracted image between the initial RI and the 8 weeks RI, a mean \n\nvalue of 98.43 \u00b1 24.33mm\u00b2 was found for the ANB-R in the TG and 102.30 \u00b1 \n\n16.51mm\u00b2 in the CG. The differences between groups were not statistically \n\nsignificant (p= 0.752). The percentage of bone fill after 8 weeks (BF-R 8) of Surgery 2 \n\nfor TG was 78.41 \u00b1 11.06% and for CG was 79.42 \u00b1 7.58 % (p= 0,754). In the \n\nevaluation between the initial RI and the 16 weeks RI, a mean value of ANB-R for the \n\nTG and for the CG was 103.54 \u00b1 19.69mm\u00b2 and 108.12 \u00b1 21.96mm\u00b2, respectively. \n\nSimilarly, no statistically significant differences were observed between groups (p= \n\n0.599). The BF-R at 16 weeks (BF-R 16) for TG and CG was 83.38 \u00b1 7.85 % and \n\n83.68 \u00b1 11.03 % respectively (p= 0.916) (Figure 1). \n\nIn both groups, no detectable radiographic differences could be found through \n\nimaging subtraction, when considering 8 weeks RI and 16 weeks RI. Using intra-\n\ngroup analysis, both for the TG and CG, no statistically significant differences were \n\n\n\n 91\n\nobserved between the subtracted images I-8 and I-16: p=0.115 for both groups \n\n(Table 3). \n\nConsidering BD-R, in the 8 weeks radiographic evaluation, the mean value for \n\nTG was 116.44 \u00b1 16.37, and for CG it was 119.77 \u00b1 26.88, with no statistically \n\nsignificant difference between groups (p=0.463). The mean value of BD-R at 16 \n\nweeks following GBR was 129.11 \u00b1 15.70 for TG and 125.77 \u00b1 13.35 for CG, and this \n\ndifference was also not statistically significant (p=0.686). (Figure 2). \n\n\n\n 92\n\nDiscussion  \n\n \n\n Guided bone regeneration has been successfully used in the treatment of \n\nseveral types of bone defects. A number of materials, non-absorbable and \n\nabsorbable, have been used as membranes, with similar results in terms of bone \n\nneoformation (Hockers, et al. 1999, Polimeni, et al. 2008, Trombelli, et al. 2008, \n\nThomaidis, et al. 2008, Schwarz, et al. 2008). \n\nIn 1994, Acellular Dermal Matrix was introduced in Periodontology. This \n\nhuman-skin-derived material was initially recommended to mucogingival procedures \n\nas an alternative to autogenous connective tissue grafts(Novaes, Grisi, Molina, \n\nSouza, Taba &amp; Grisi 2001, Paolantonio, et al. 2002, Yan, et al. 2006, Cummings, et \n\nal. 2005). Therefore, ADM started to be used in procedures for root coverage and \n\nsoft tissue corrections in alveolar ridges, providing positive results, particularly with \n\nregard to gain in thickness and width of keratinized tissue (Batista, Batista &amp; Novaes \n\n2001, Barros, et al. 2005). Considering these results and the structural \n\ncharacteristics of the biomaterial, studies were carried out using the acellular dermal \n\nmatrix GBR procedures. Therefore, as an alternative to other kinds of membrane, \n\nADM was used in fresh extraction sockets, in association with implants placement \n\nand in prevention of ridge deformities, demonstrating satisfactory results (Novaes &amp; \n\nSouza 2001, Novaes, Papalexiou, Luczyszyn, Muglia, Souza &amp; Taba Junior 2002, \n\nBatista, Batista &amp; Novaes 2001) (Griffin, Cheung &amp; Hirayama 2004, Fowler, et al. \n\n2000) (Luczyszyn, et al. 2005). Andrade et al., in 2007, confirmed the capacity of \n\nADM to act as a membrane in GTR procedures. However, no randomized and \n\ncontrolled study in GBR had been made, to verify these positive clinical results and \n\nassess the amount and quality of newly-formed bone. \n\n\n\n 93\n\nThe results of this study demonstrated that the acellular dermal matrix was \n\neffective as a membrane in GBR, maintaining the space, avoiding undesirable tissue \n\nmigration and allowing bone neoformation, with similar results to those obtained with \n\na bioabsorbable membrane. The bone defects created in this study had critical \n\ndimensions (12x8x10mm), as stated by Schenk et al. in 1994(Schenk RK 1994) - \n\nthere was no adequate bone regeneration without the use of a membrane. These \n\nauthors verified that the negative control group showed incomplete bone \n\nregeneration, with persistent bone defects, whereas in the test groups, it was \n\nobserved an improved healing process; however total regeneration of these defects \n\nhad not been reached at the end of 16 weeks. Bornstein et al. (2007)(Bornstein, et al. \n\n2007), nevertheless, didn\u2019t find differences between negative control group and test \n\ngroup regarding bone gain when a collagen membrane was used \u2013 both groups \n\ndidn\u2019t demonstrate significant bone neoformation. The histological analysis of the \n\npresent study showed in both groups, after the same healing period, the formation of \n\nmature bone with concentric lamellae, haversian canals and also areas of bone \n\nremodeling, mainly in the edges of the defects. Trabecular bone and immature bone \n\nof varied dimensions were also found, as already observed in other studies (Schenk \n\nRK 1994 22, Bornstein, Bosshardt &amp; Buser 2007 61). Thus, as suggested by Shenck \n\net al (1994) and Jovanovic et al (2007) (Jovanovic, et al. 2007), an extended healing \n\nperiod of more than 4 months would be necessary for complete bone regeneration. \n\nHistomorphometrically, both groups showed similar results. The amount of \n\nnewly-formed bone in the test group corresponded to 58.99% of the area of new \n\ntissues, while in the control group this percentage reached 61.00%. These results are \n\nsimilar to those obtained by Schenk, who reported that the newly-formed bone \n\noccupied 55% of the defect volume in the same period of time. The mean value of \n\n\n\n 94\n\nnew bone in the group treated with ADM was 42.05mm\u00b2 and, in the control group, it \n\nwas 43.96mm\u00b2, a numerically superior result than that reported by Bornstein et al \n\n(2007)(Bornstein, Bosshardt &amp; Buser 2007) (39,09 mm2 of new bone area in defects \n\ntreated with an experimental collagen membrane after 4 months of healing). The \n\nbone height (Kikuchi, et al. 2004) observed in the TG and CG was respectively of \n\n7.21 mm and 7.70 mm, which correspond to 90.12% and 96.25% of the surgically \n\ncreated defect height. The percentage of cortical bone after 4 months of healing was \n\n42.47% of ANB in the TG and 38.08% of ANB in the CG (p=0.463), corroborating the \n\nresults of Schenk et al.(Schenk RK 1994), who observed approximately 38% of \n\ncortical bone. Jovanovic et al. (2007)(Jovanovic, Hunt, Bernard, Spiekermann, \n\nWozney &amp; Wikesjo 2007), on the other hand, reported a bone density which varied \n\nfrom 50 to 57% in control sites or in sites treated with GBR. \n\nRadiographically, the areas with higher radiopacity in the subtraction \n\nprocedure were interpreted as a possible bone neoformation. It was observed that 8 \n\nweeks after GBR, the TG showed a bone filling rate of 78.41%, and the CG, a rate of \n\n79.42%, when compared to the initial radiographic area of the defect. After 16 weeks, \n\nthe subtracted image suggested a newly-formed bone percentage of 83.38% for the \n\nTG, and of 83.68% for the CG. Once again, the groups showed similar results with \n\nno statistical difference between them. Jovanovic et al 2007(Jovanovic, Hunt, \n\nBernard, Spiekermann, Wozney &amp; Wikesjo 2007) reported complete bone filling \n\nradiographically; however, they evaluated conventional images instead of subtraction \n\nimages \n\nIn both groups, a significative increase in gray levels was observed when the \n\ninitial radiograph was compared with those taken at 8 and at 16 weeks, which can be \n\ninterpreted as an increase of formation or mineralization of bone tissue. However, \n\n\n\n 95\n\nthere was no statistically significant difference between the periods of 8 and 16 \n\nweeks. These findings suggest that the bone formation was achieved mainly in the \n\nfirst 8 weeks. \n\nThe clinical results of this study were similar in both groups \u2013 there was an \n\nincrease in thickness of keratinized tissue. In the test group, a significative increase \n\nin the lingual TKT was observed (p=0.027), corroborating previous studies, which \n\ndemonstrated the capacity of ADM to increase the thickness of keratinized \n\ntissue(Aichelmann-Reidy 2001, Paolantonio, Dolci, Esposito, D'Archivio, Lisanti, Di \n\nLuccio &amp; Perinetti 2002, Fowler, Breault &amp; Rebitski 2000, Araujo, et al. 1998, \n\nMellonig, et al. 1998, Felipe, et al. 2007) (Andrade, et al. 2008).(Novaes &amp; Souza \n\n2001). Regarding the width of keratinized tissue, both groups demonstrated a \n\ndecrease of this parameter. In TG, a significative decrease in buccal and lingual WKT \n\nwas noticed; in the CG, this difference was statistically significant only for the lingual \n\nWKT. In both groups, the flap was divided beyond the mucogingival junction and was \n\nextended until the partial-thickness flap could be passively positioned coronally, to \n\nprovide complete coverage of the ADM or the absorbable membrane. Due to the \n\ncoronal displacement of the flap, the mucogingival line was slightly positioned in a \n\ncoronal direction, when compared to its original position; this fact that can explain a \n\ncertain decrease in the width of keratinized tissue in both groups. It is well-known that \n\nthe mucogingival line tends to return to its original position in the post-operatory \n\nperiod(Ainamo, et al. 1992); however, 4 months does not seem to have been enough \n\ntime for it occurs. Furthermore, the four month healing period might have been \n\ninsufficient for the ADM to provide, by itself, an increase in WKT, which is in \n\naccordance with the study of Souza et al (2008) (de Souza, et al. 2008). These \n\nauthors, in root coverage procedures, observed that 6 and 12 months had not yet \n\n\n\n 96\n\nbeen a satisfactory time period for a significant increase in width of keratinized tissue \n\nto occur. Furthermore, it is important to mention that in the case study of Novaes Jr. \n\nand Souza (2001)(Novaes &amp; Souza 2001), the ADM was intentionally left exposed to \n\nincrease the width of keratinized mucosa, a procedure that was not performed in this \n\nstudy, in which the ADM was completely covered by the flap. The current literature \n\ndemonstrates confliting results related to width of keratinized tissue after the use of \n\nacellular dermal matrix (Novaes AB Jr 2001, Felipe, Andrade, Grisi, Souza, Taba, \n\nPalioto &amp; Novaes 2007, Andrade, Felipe, Novaes, Souza, Taba, Palioto &amp; Grisi \n\n2008), since it is known that the increase of this tissue depends on the migration of \n\ncells with the capacity to stimulate the differentiation of the mucosa, a fact that \n\nvariates among different species and even among members of the same species \n\n(Paolantonio, Dolci, Esposito, D'Archivio, Lisanti, Di Luccio &amp; Perinetti 2002). \n\nAlthough similarities were found between most of the evaluated parameters in \n\nthis study, it could be observed that the post-operatory healing of the group treated \n\nwith ADM was the most satisfactory one. In Control group, there was exposure of the \n\nmembrane in two animals, and in one of them this exposure was so large that it had \n\nto be excluded from the study. For the dog, which still remained in this study, \n\nmembrane contamination was controlled with 0.12% chlorhexidine digluconate \n\nsolution topically and systemic antibiotic therapy, as described by several authors in \n\nhuman studies (dos Anjos, et al. 1998, Simonpietri, et al. 2000, Villaca, et al. 2004). \n\nClinically, it was observed in this case degradation of the exposed portion of the \n\nmembrane and, histologically, a small migration of gingival tissues towards the \n\ninterior of the bone defect, suggesting that in this site, the barrier function of the \n\nabsorbable membrane was compromised. These findings corroborate several \n\nstudies, which have demonstrated that absorbable membranes, when exposed to the \n\n\n\n 97\n\noral cavity, suffer premature degradation in the post-operatory period (Simion 1997, \n\nMachtei 2001 , Lorenzoni, et al. 2002, Tal, et al. 2008). However this incident did not \n\nhave a reflect in the final results of the control group \u2013 the results showed by this \n\nanimal did not substantially differ from the others in the same group \n\nThe clinical, histomorphometric and radiographic results obtained in this study \n\ndemonstrated that GBR technique was effective in both groups (Acellular Dermal \n\nMatrix and Absorbable Membrane), with no statistically significant differences \n\nbetween them. Thus, they indicate that the acellular dermal matrix has the capacity \n\nto act as a physical barrier in guided bone regeneration  \n\n\n\n 98\n\nACKNOWLEDGMENTS \n\nThe authors thank The State of S\u00e3o Paulo Research Foundation (FAPESP; protocol \n\nnumber 06.1.420.53.8) for financial support of this study. \n\n\n\n 99\n\nTable 1 \nComparison between the Test (TG) and Control Groups (CG) for the mean \nvalues (mm) of the clinical parameters for Clinical Exams 1 and 2.  \n \n TG CG   TG CG   \n\nParameters Exam 1 Exam 1 p \u2020 Exam 2 Exam 2 p \u2020 \n\nB-TKT  1.27 \u00b1 0.53 1.28 \u00b1 0.53  0.916 1.75 \u00b1 0.36 2.14 \u00b1 0.72  0.173 \n\nO-TKT  1.60 \u00b1 0.43 1.49 \u00b1 0.56  0.917 1.88 \u00b1 0.31 1.88 \u00b1 0.64  0.686 \n\nL-TKT  0.97 \u00b1 0.17 1.01 \u00b1 0.28  0.752 1.44 \u00b1 0.24 1.22 \u00b1 0.66  0.60 \n\nB-WKT  3.90 \u00b1 0.75 4.77 \u00b1 0.98  0.173 3.21 \u00b1 0.85 4.41 \u00b1 1.05   0.028* \nL-WKT  6.78 \u00b1 1.63 6.98 \u00b1 0.65  1.0 5.19 \u00b1 1.55 4.19 \u00b1 1.55  0.249 \n\nB-TKT: thickness of keratinized tissue in the buccal area; O-TKT: thickness of keratinized \ntissue in the occlusal area; L-TKT: thickness of keratinized tissue in the lingual area; B-WKT: \nwidth of keratinized tissue in the buccal area; L-WKT: width of keratinized tissue in the lingual \narea. \n\u2020 Wilcoxon Test; \n* Statistically significant difference (p&lt;0.05). \n \n\nTable 2  \nComparison between Clinical Exams 1 and 2 and the mean values (mm) of the \nclinical parameters of the Test and Control Groups (intra-group comparison). \n \n Test Group Control Group \n\nParameters Exam 1 Exam 2 p \u2020 Exam 1 Exam 2 p \u2020 \n\nB-TKT 1.27 \u00b1 0.53 1.75 \u00b1 0.36 0.075 1.28 \u00b1 0.53 2.14 \u00b1 0.72 0.075  \n\nO-TKT   1.60 \u00b1 0.43 1.88 \u00b1 0.31 0.463  1.49 \u00b1 0.56 1.88 \u00b1 0.64 0.463 \n\nL-TKT   0.97 \u00b1 0.17 1.44 \u00b1 0.24 0.027*  1.01 \u00b1 0.28 1.22 \u00b1 0.66 0.345 \n\n B-WKT  3.90 \u00b1 0.75 3.21 \u00b1 0.85 0.028* 4.77 \u00b1 0.98 4.41 \u00b1 1.05 0.463 \n\nL-WKT  6.78 \u00b1 1.63 5.19 \u00b1 1.55 0.028* 6.98 \u00b1 0.65 4.19 \u00b1 1.55   0.028* \nB-TKT: thickness of keratinized tissue in the buccal area; O-TKT: thickness of keratinized \ntissue in the occlusal area; L-TKT: thickness of keratinized tissue in the lingual area; B-WKT: \nwidth of keratinized tissue in the buccal area; L-WKT: width of keratinized tissue in the lingual \narea. \n\u2020 Wilcoxon Test; \n* Statistically significant difference (p&lt;0.05). \n \n\n\n\n 100\n\nFigure 1 \nComparison between the Test (TG) and Control Groups (CG) for the mean \nvalues of ANB-R, at 8 weeks (I-8), and at 16 weeks (I-16). \n \n\nANO-R\n\n0\n\n20\n\n40\n\n60\n\n80\n\n100\n\n120\n\n140\n\nGT I-8 GC I-8 GT I-16 GC I-16\n\nGrupos\n\nm\nm\n\n2\n\n \n\n \n\nTable 3 \nIntra-group Comparison for ANB-R formed at 8 weeks and at 16 weeks. \n\nANB-R 8 weeks 16 weeks Value of p \u2020 \n\nTG 98.43 \u00b1 24.33 103.54 \u00b1 19.69 0.115 \n\nCG 102.30 \u00b1 16.51 108.12 \u00b1 21.96 0.115 \n\nANB-R:  Radiographic area of new bone; TG: Test Group; CG: Control Group. \n\u2020 Wilcoxon Test. \n\n \n\nANB-R\n\nTG I-8 TG I-16 CG I-8 CG I-16 \n\nGroups\n\n\n\n 101\n\nFigure 2  \nComparison between Test (TG) and Control Groups (CG) for the total mean \nvalues of BD-R at 8 weeks, and 16 weeks. \n \n\nDO-R\n\n0\n20\n40\n60\n80\n\n100\n120\n140\n160\n\n8 GT 8 GC 16 GT 16 GC\n\nGrupos\n\nN\n\u00edv\n\nei\ns \n\nde\n C\n\nin\nza\n\n \n\nG\nra\n\nys\nca\n\nle\n \n\nBD-R \n\n8 TG 16 TG 8 CG 16 CG \nGroups \n\n\n\n 102\n\nReferences \n\n \n\nSeibert, J. &amp; Nyman, S., (1990) Localized ridge augmentation in dogs: A pilot study \n\nusing membranes and hydroxyapatite. J Periodontol 61: 157-165. \n\nBuser, D., Dula, K., Belser, U., Hirt, H.P. &amp; Berthold, H., (1993) Localized ridge \n\naugmentation using guided bone regeneration. 1. Surgical procedure in the maxilla. \n\nInt J Periodontics Restorative Dent 13: 29-45. \n\nMecall, R.A. &amp; Rosenfeld, A.L., (1996) Influence of residual ridge resorption patterns \n\non fixture placement and tooth position, part iii: Presurgical assessment of ridge \n\naugmentation requirements. Int J Periodontics Restorative Dent 16: 322-337. \n\nFiorellini, J.P. &amp; Nevins, M.L., (2003) Localized ridge augmentation/preservation. A \n\nsystematic review. Ann Periodontol 8: 321-327. \n\nChiapasco, M., Zaniboni, M. &amp; Boisco, M., (2006) Augmentation procedures for the \n\nrehabilitation of deficient edentulous ridges with oral implants. Clin Oral Implants Res \n\n17 Suppl 2: 136-159. \n\nNevins, M.M., J.T. , (1992 ) Enhancement of the damaged edentulous ridge to \n\nreceive dental implants: A combination of allograft and the gore-tex membrane. \n\nInternational Journal of Periodonticsand Restorative Dentistry 12: 97\u2013111. \n\nNovaes, A.B., Jr. &amp; Souza, S.L., (2001) Acellular dermal matrix graft as a membrane \n\nfor guided bone regeneration: A case report. Implant Dent 10: 192-196. \n\nNovaes, A.B., Jr., Papalexiou, V., Luczyszyn, S.M., Muglia, V.A., Souza, S.L. &amp; Taba \n\nJunior, M., (2002) Immediate implant in extraction socket with acellular dermal matrix \n\ngraft and bioactive glass: A case report. Implant Dent 11: 343-348. \n\n\n\n 103\n\nGriffin, T.J., Cheung, W.S. &amp; Hirayama, H., (2004) Hard and soft tissue augmentation \n\nin implant therapy using acellular dermal matrix. Int J Periodontics Restorative Dent \n\n24: 352-361. \n\nNowzari, H. &amp; Slots, J., (1994) Microorganisms in polytetrafluoroethylene barrier \n\nmembranes for guided tissue regeneration. J Clin Periodontol 21: 203-210. \n\nRossa, M.L., Lima, L.A., Pustiglioni, F.E., Hespanhol, A.M., Kon, S., Grigolli Filho, J. \n\n&amp; Novo, N.F., (2006) Sem analyses of bacterial contamination of e-ptfe membranes \n\nand gtr clinical results. J Int Acad Periodontol 8: 115-124. \n\nMachtei, E.E., (2001) The effect of membrane exposure on the outcome of \n\nregenerative procedures in humans: A meta-analysis. J Periodontol 72: 512-516. \n\nde Andrade, P.F., de Souza, S.L., de Oliveira Macedo, G., Novaes, A.B., Jr., de \n\nMoraes Grisi, M.F., Taba, M., Jr. &amp; Palioto, D.B., (2007) Acellular dermal matrix as a \n\nmembrane for guided tissue regeneration in the treatment of class II furcation \n\nlesions: A histometric and clinical study in dogs. J Periodontol 78: 1288-1299. \n\nBatista, E.L., Jr., Batista, F.C. &amp; Novaes, A.B., Jr., (2001) Management of soft tissue \n\nridge deformities with acellular dermal matrix. Clinical approach and outcome after 6 \n\nmonths of treatment. J Periodontol 72: 265-273. \n\nAichelmann-Reidy, M.E., Yukna, R. A.,Evans, G. H.Nasr, H. F.,Mayer, E. T., (2001) \n\nClinical evaluation of acellular allograft dermis for the treatment of human gingival \n\nrecession. J Periodontol 72: 998-1005. \n\nNovaes AB Jr, G.D., Molina GO, Souza SLS, Taba M Jr, Grisi MFM., (2001) \n\nComparative 6- month clinical study of a subepithelial connective tissue graft and \n\nacellular dermal matrix for the treatment of gingival recession. J Periodontol 72: \n\n1477-1484. \n\n\n\n 104\n\nPontes, A.E., Pontes, C.C., Souza, S.L., Novaes, A.B., Jr., Grisi, M.F. &amp; Taba, M., \n\nJr., (2006) Evaluation of the efficacy of the acellular dermal matrix allograft with \n\npartial thickness flap in the elimination of gingival melanin pigmentation. A \n\ncomparative clinical study with 12 months of follow-up. J Esthet Restor Dent 18: 135-\n\n143; discussion 143. \n\nNovaes, A.B., Jr., Pontes, C.C., Souza, S.L., Grisi, M.F. &amp; Taba, M., Jr., (2002) The \n\nuse of acellular dermal matrix allograft for the elimination of gingival melanin \n\npigmentation: Case presentation with 2 years of follow-up. Pract Proced Aesthet \n\nDent 14: 619-623; quiz 624. \n\nFowler, E.B., Breault, L.G. &amp; Rebitski, G., (2000) Ridge preservation utilizing an \n\nacellular dermal allograft and demineralized freeze-dried bone allograft: Part ii. \n\nImmediate endosseous implant placement. J Periodontol 71: 1360-1364. \n\nBuser, D., Bragger, U., Lang, N.P. &amp; Nyman, S., (1990) Regeneration and \n\nenlargement of jaw bone using guided tissue regeneration. Clin Oral Implants Res 1: \n\n22-32. \n\nCaffesse RG, M.L., Quinones CR, Morrison EC. , (1997) Clinical comparison of \n\nresorbable and non-resorbable barriers for guided periodontal tissue regeneration. J \n\nClin Periodontol 24: 747-752. \n\nLindhe J, P.R., Berglundh T, Araujo M. , (1995) The effect of flap management and \n\nbioresorbable occlusive devices in gtr treatment of degree iii furcation defects. An \n\nexperimental study in dogs. J Clin Periodontol 22: 276-283. \n\nNovaes, A.B., Jr., Grisi, D.C., Molina, G.O., Souza, S.L., Taba, M., Jr. &amp; Grisi, M.F., \n\n(2001) Comparative 6-month clinical study of a subepithelial connective tissue graft \n\nand acellular dermal matrix graft for the treatment of gingival recession. J Periodontol \n\n72: 1477-1484. \n\n\n\n 105\n\nSchenk RK, B.D., Hardwick WR, Dahlin C., (1994) Healing pattern of bone \n\nregeneration in membrane-protected defects: A histologic study in the canine \n\nmandible. Int J Oral Maxillofac Implants 9: 13-29. \n\nBittar-Cortez, J.A., Passeri, L.A., Boscolo, F.N. &amp; Haiter-Neto, F., (2006) Comparison \n\nof hard tissue density changes around implants assessed in digitized conventional \n\nradiographs and subtraction images. Clin Oral Implants Res 17: 560-564. \n\nHwang, Y.J., Fien, M.J., Lee, S.S., Kim, T.I., Seol, Y.J., Lee, Y.M., Ku, Y., Rhyu, I.C., \n\nChung, C.P. &amp; Han, S.B., (2008) Effect of scaling and root planing on alveolar bone \n\nas measured by subtraction radiography. J Periodontol 79: 1663-1669. \n\nHockers, T., Abensur, D., Valentini, P., Legrand, R. &amp; Hammerle, C.H., (1999) The \n\ncombined use of bioresorbable membranes and xenografts or autografts in the \n\ntreatment of bone defects around implants. A study in beagle dogs. Clin Oral \n\nImplants Res 10: 487-498. \n\nPolimeni, G., Koo, K.T., Pringle, G.A., Agelan, A., Safadi, F.F. &amp; Wikesjo, U.M., \n\n(2008) Histopathological observations of a polylactic acid-based device intended for \n\nguided bone/tissue regeneration. Clin Implant Dent Relat Res 10: 99-105. \n\nTrombelli, L., Farina, R., Marzola, A., Itro, A. &amp; Calura, G., (2008) Gbr and \n\nautogenous cortical bone particulate by bone scraper for alveolar ridge \n\naugmentation: A 2-case report. Int J Oral Maxillofac Implants 23: 111-116. \n\nThomaidis, V., Kazakos, K., Lyras, D.N., Dimitrakopoulos, I., Lazaridis, N., Karakasis, \n\nD., Botaitis, S. &amp; Agrogiannis, G., (2008) Comparative study of 5 different \n\nmembranes for guided bone regeneration of rabbit mandibular defects beyond critical \n\nsize. Med Sci Monit 14: BR67-73. \n\nSchwarz, F., Rothamel, D., Herten, M., Wustefeld, M., Sager, M., Ferrari, D. &amp; \n\nBecker, J., (2008) Immunohistochemical characterization of guided bone \n\n\n\n 106\n\nregeneration at a dehiscence-type defect using different barrier membranes: An \n\nexperimental study in dogs. Clin Oral Implants Res 19: 402-415. \n\nPaolantonio, M., Dolci, M., Esposito, P., D'Archivio, D., Lisanti, L., Di Luccio, A. &amp; \n\nPerinetti, G., (2002) Subpedicle acellular dermal matrix graft and autogenous \n\nconnective tissue graft in the treatment of gingival recessions: A comparative 1-year \n\nclinical study. J Periodontol 73: 1299-1307. \n\nYan, J.J., Tsai, A.Y., Wong, M.Y. &amp; Hou, L.T., (2006) Comparison of acellular dermal \n\ngraft and palatal autograft in the reconstruction of keratinized gingiva around dental \n\nimplants: A case report. Int J Periodontics Restorative Dent 26: 287-292. \n\nCummings, L.C., Kaldahl, W.B. &amp; Allen, E.P., (2005) Histologic evaluation of \n\nautogenous connective tissue and acellular dermal matrix grafts in humans. J \n\nPeriodontol 76: 178-186. \n\nBarros, R.R., Novaes, A.B., Jr., Grisi, M.F., Souza, S.L., Taba, M., Jr. &amp; Palioto, D.B., \n\n(2005) New surgical approach for root coverage of localized gingival recession with \n\nacellular dermal matrix: A 12-month comparative clinical study. J Esthet Restor Dent \n\n17: 156-164; discussion 164. \n\nFowler, E.B., Breault, L.G. &amp; Rebitski, G., (2000) Ridge preservation utilizing an \n\nacellular dermal allograft and demineralized freeze-dried bone allograft: Part i. A \n\nreport of 2 cases. J Periodontol 71: 1353-1359. \n\nLuczyszyn, S.M., Papalexiou, V., Novaes, A.B., Jr., Grisi, M.F., Souza, S.L. &amp; Taba, \n\nM., Jr., (2005) Acellular dermal matrix and hydroxyapatite in prevention of ridge \n\ndeformities after tooth extraction. Implant Dent 14: 176-184. \n\nBornstein, M.M., Bosshardt, D. &amp; Buser, D., (2007) Effect of two different \n\nbioabsorbable collagen membranes on guided bone regeneration: A comparative \n\nhistomorphometric study in the dog mandible. J Periodontol 78: 1943-1953. \n\n\n\n 107\n\nJovanovic, S.A., Hunt, D.R., Bernard, G.W., Spiekermann, H., Wozney, J.M. &amp; Wikesjo, \n\nU.M., (2007) Bone reconstruction following implantation of rhbmp-2 and guided bone \n\nregeneration in canine alveolar ridge defects. Clin Oral Implants Res 18: 224-230. \n\nKikuchi, M., Koyama, Y., Yamada, T., Imamura, Y., Okada, T., Shirahama, N., Akita, \n\nK., Takakuda, K. &amp; Tanaka, J., (2004) Development of guided bone regeneration \n\nmembrane composed of beta-tricalcium phosphate and poly (l-lactide-co-glycolide-\n\nco-epsilon-caprolactone) composites. Biomaterials 25: 5979-5986. \n\nAraujo, M.G., Berglundh, T. &amp; Lindhe, J., (1998) Gtr treatment of degree iii furcation \n\ndefects with 2 different resorbable barriers. An experimental study in dogs. J Clin \n\nPeriodontol 25: 253-259. \n\nMellonig, J.T., Nevins, M. &amp; Sanchez, R., (1998) Evaluation of a bioabsorbable \n\nphysical barrier for guided bone regeneration. Part ii. Material and a bone \n\nreplacement graft. Int J Periodontics Restorative Dent 18: 129-137. \n\nFelipe, M.E., Andrade, P.F., Grisi, M.F., Souza, S.L., Taba, M., Palioto, D.B. &amp; \n\nNovaes, A.B., (2007) Comparison of two surgical procedures for use of the acellular \n\ndermal matrix graft in the treatment of gingival recessions: A randomized controlled \n\nclinical study. J Periodontol 78: 1209-1217. \n\nAndrade, P.F., Felipe, M.E., Novaes, A.B., Jr., Souza, S.L., Taba, M., Jr., Palioto, \n\nD.B. &amp; Grisi, M.F., (2008) Comparison between two surgical techniques for root \n\ncoverage with an acellular dermal matrix graft. J Clin Periodontol 35: 263-269. \n\nAinamo, A., Bergenholtz, A., Hugoson, A. &amp; Ainamo, J., (1992) Location of the \n\nmucogingival junction 18 years after apically repositioned flap surgery. J Clin \n\nPeriodontol 19: 49-52. \n\nde Souza, S.L., Novaes, A.B., Jr., Grisi, D.C., Taba, M., Jr., Grisi, M.F. &amp; de Andrade, \n\nP.F., (2008) Comparative clinical study of a subepithelial connective tissue graft and \n\n\n\n 108\n\nacellular dermal matrix graft for the treatment of gingival recessions: Six- to 12-month \n\nchanges. J Int Acad Periodontol 10: 87-94. \n\ndos Anjos, B., Novaes, A.B., Jr., Meffert, R. &amp; Barboza, E.P., (1998) Clinical \n\ncomparison of cellulose and expanded polytetrafluoroethylene membranes in the \n\ntreatment of class ii furcations in mandibular molars with 6-month re-entry. J \n\nPeriodontol 69: 454-459. \n\nSimonpietri, C.J., Novaes, A.B., Jr., Batista, E.L., Jr. &amp; Filho, E.J., (2000) Guided \n\ntissue regeneration associated with bovine-derived anorganic bone in mandibular \n\nclass ii furcation defects. 6-month results at re-entry. J Periodontol 71: 904-911. \n\nVillaca, J.H., Rodrigues, D.C., Novaes, A.B., Jr., Taba, M., Jr., Souza, S.L. &amp; Grisi, \n\nM.F., (2004) Root trunk concavities as a risk factor for regenerative procedures of \n\nclass ii furcation lesions in humans. J Periodontol 75: 1493-1499. \n\nSimion, M., Misitano, U., Gionso, L. &amp; Salvato, A.  , (1997) Treatment of dehiscences \n\nand fenestrations around dental implants using resorbable and nonresorbable \n\nmembranes associated with bone autografts: A comparative clinical study. \n\nInternational Journal of Oral &amp; Maxillofacial Implants 12: 159\u2013167 \n\nMachtei, E.E., (2001 ) The effect of membrane exposure on the outcome of \n\nregenerative proceduresin humans: A meta-analysis. . J Periodontol 72: 512\u2013516 \n\nLorenzoni, M., Pertl, C., Polansky, R.A., Jakse, N. &amp; Wegscheider, W.A., (2002) \n\nEvaluation of implants placed with barrier membranes. A restrospective follow-up \n\nstudy up to five years. Clin Oral Implants Res 13: 274-280. \n\nTal, H., Kozlovsky, A., Artzi, Z., Nemcovsky, C.E. &amp; Moses, O., (2008) Cross-linked \n\nand non-cross-linked collagen barrier membranes disintegrate following surgical \n\nexposure to the oral environment: A histological study in the cat. Clin Oral Implants \n\nRes 19: 760-766."}]}}}